EP1807209A2 - Devices for carrying out and diagnosing microarray experiments - Google Patents
Devices for carrying out and diagnosing microarray experimentsInfo
- Publication number
- EP1807209A2 EP1807209A2 EP05813339A EP05813339A EP1807209A2 EP 1807209 A2 EP1807209 A2 EP 1807209A2 EP 05813339 A EP05813339 A EP 05813339A EP 05813339 A EP05813339 A EP 05813339A EP 1807209 A2 EP1807209 A2 EP 1807209A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- microarray
- wells
- probe
- microarrays
- microtiter plate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002493 microarray Methods 0.000 title claims abstract description 289
- 238000002474 experimental method Methods 0.000 title claims abstract description 61
- 239000000523 sample Substances 0.000 claims abstract description 219
- 238000001514 detection method Methods 0.000 claims abstract description 108
- 230000003993 interaction Effects 0.000 claims abstract description 97
- 238000000034 method Methods 0.000 claims abstract description 89
- 238000006243 chemical reaction Methods 0.000 claims description 152
- 238000012545 processing Methods 0.000 claims description 87
- 239000007788 liquid Substances 0.000 claims description 31
- 239000000853 adhesive Substances 0.000 claims description 28
- 230000001070 adhesive effect Effects 0.000 claims description 28
- 239000002244 precipitate Substances 0.000 claims description 24
- 238000003860 storage Methods 0.000 claims description 16
- 230000003287 optical effect Effects 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 14
- 230000015572 biosynthetic process Effects 0.000 claims description 13
- 125000006850 spacer group Chemical group 0.000 claims description 13
- 229920001971 elastomer Polymers 0.000 claims description 11
- 239000003550 marker Substances 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 238000005516 engineering process Methods 0.000 claims description 7
- 238000003384 imaging method Methods 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 239000000806 elastomer Substances 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 4
- 238000012937 correction Methods 0.000 claims description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 2
- 239000012780 transparent material Substances 0.000 claims description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims 2
- 229940088598 enzyme Drugs 0.000 claims 2
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 claims 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 claims 1
- HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 claims 1
- LVSPDZAGCBEQAV-UHFFFAOYSA-N 4-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=CC=C(Cl)C2=C1 LVSPDZAGCBEQAV-UHFFFAOYSA-N 0.000 claims 1
- OXEUETBFKVCRNP-UHFFFAOYSA-N 9-ethyl-3-carbazolamine Chemical compound NC1=CC=C2N(CC)C3=CC=CC=C3C2=C1 OXEUETBFKVCRNP-UHFFFAOYSA-N 0.000 claims 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims 1
- 108010015776 Glucose oxidase Proteins 0.000 claims 1
- 239000004366 Glucose oxidase Substances 0.000 claims 1
- IYXMNTLBLQNMLM-UHFFFAOYSA-N benzene-1,4-diamine;hydron;dichloride Chemical compound Cl.Cl.NC1=CC=C(N)C=C1 IYXMNTLBLQNMLM-UHFFFAOYSA-N 0.000 claims 1
- 229940116332 glucose oxidase Drugs 0.000 claims 1
- 235000019420 glucose oxidase Nutrition 0.000 claims 1
- INCIMLINXXICKS-UHFFFAOYSA-M pyronin Y Chemical compound [Cl-].C1=CC(=[N+](C)C)C=C2OC3=CC(N(C)C)=CC=C3C=C21 INCIMLINXXICKS-UHFFFAOYSA-M 0.000 claims 1
- 239000000126 substance Substances 0.000 description 45
- 239000000463 material Substances 0.000 description 41
- 238000012360 testing method Methods 0.000 description 40
- 102000039446 nucleic acids Human genes 0.000 description 34
- 150000007523 nucleic acids Chemical class 0.000 description 34
- 108020004707 nucleic acids Proteins 0.000 description 33
- 238000003491 array Methods 0.000 description 30
- 238000009396 hybridization Methods 0.000 description 27
- 238000000018 DNA microarray Methods 0.000 description 26
- 239000000243 solution Substances 0.000 description 25
- 239000000758 substrate Substances 0.000 description 21
- 239000011159 matrix material Substances 0.000 description 20
- -1 polypropylene Polymers 0.000 description 20
- 238000003556 assay Methods 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 17
- 102000053602 DNA Human genes 0.000 description 17
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 16
- 238000011049 filling Methods 0.000 description 15
- 239000011521 glass Substances 0.000 description 15
- 238000003752 polymerase chain reaction Methods 0.000 description 15
- 238000013019 agitation Methods 0.000 description 14
- 239000000872 buffer Substances 0.000 description 14
- 108091034117 Oligonucleotide Proteins 0.000 description 13
- 230000008901 benefit Effects 0.000 description 12
- 229920003023 plastic Polymers 0.000 description 12
- 239000004033 plastic Substances 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 11
- 238000011534 incubation Methods 0.000 description 11
- 235000012431 wafers Nutrition 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 239000004417 polycarbonate Substances 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 238000005286 illumination Methods 0.000 description 9
- 229920000136 polysorbate Polymers 0.000 description 9
- 238000001556 precipitation Methods 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 229920002477 rna polymer Polymers 0.000 description 9
- 241000894007 species Species 0.000 description 9
- 239000004743 Polypropylene Substances 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 229960002685 biotin Drugs 0.000 description 8
- 235000020958 biotin Nutrition 0.000 description 8
- 239000011616 biotin Substances 0.000 description 8
- 239000002131 composite material Substances 0.000 description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 8
- 229920001155 polypropylene Polymers 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 239000012491 analyte Substances 0.000 description 7
- 229920001222 biopolymer Polymers 0.000 description 7
- 230000000903 blocking effect Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000003992 Peroxidases Human genes 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
- 230000003321 amplification Effects 0.000 description 6
- 230000027455 binding Effects 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 230000010354 integration Effects 0.000 description 6
- 238000002372 labelling Methods 0.000 description 6
- 239000003068 molecular probe Substances 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 108040007629 peroxidase activity proteins Proteins 0.000 description 6
- 229920000515 polycarbonate Polymers 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 230000002792 vascular Effects 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000005755 formation reaction Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 238000010348 incorporation Methods 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 238000003908 quality control method Methods 0.000 description 5
- 239000005060 rubber Substances 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 239000011534 wash buffer Substances 0.000 description 5
- 239000004677 Nylon Substances 0.000 description 4
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 4
- 108010067902 Peptide Library Proteins 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 239000002751 oligonucleotide probe Substances 0.000 description 4
- 239000013610 patient sample Substances 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- 229910052709 silver Inorganic materials 0.000 description 4
- 239000004332 silver Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000012192 staining solution Substances 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 4
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 238000001917 fluorescence detection Methods 0.000 description 3
- 239000002241 glass-ceramic Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 239000002853 nucleic acid probe Substances 0.000 description 3
- 229920000620 organic polymer Polymers 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 238000009589 serological test Methods 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- WFZFMHDDZRBTFH-CZEFNJPISA-N 2-[(e)-2-(5-carbamimidoyl-1-benzofuran-2-yl)ethenyl]-1-benzofuran-5-carboximidamide;dihydrochloride Chemical compound Cl.Cl.NC(=N)C1=CC=C2OC(/C=C/C=3OC4=CC=C(C=C4C=3)C(=N)N)=CC2=C1 WFZFMHDDZRBTFH-CZEFNJPISA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 2
- 229930010555 Inosine Natural products 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 229940115457 cetyldimethylethylammonium bromide Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- VUFOSBDICLTFMS-UHFFFAOYSA-M ethyl-hexadecyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)CC VUFOSBDICLTFMS-UHFFFAOYSA-M 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000003205 genotyping method Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 229960003786 inosine Drugs 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000007769 metal material Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 238000005496 tempering Methods 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 229910004261 CaF 2 Inorganic materials 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- 241001631457 Cannula Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 238000012351 Integrated analysis Methods 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 241000582786 Monoplex Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 108020001027 Ribosomal DNA Proteins 0.000 description 1
- 229910052772 Samarium Inorganic materials 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 239000004830 Super Glue Substances 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229910052769 Ytterbium Inorganic materials 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000003522 acrylic cement Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- AOJOEFVRHOZDFN-UHFFFAOYSA-N benzyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1=CC=CC=C1 AOJOEFVRHOZDFN-UHFFFAOYSA-N 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 239000005352 borofloat Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000012297 crystallization seed Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- UHESRSKEBRADOO-UHFFFAOYSA-N ethyl carbamate;prop-2-enoic acid Chemical compound OC(=O)C=C.CCOC(N)=O UHESRSKEBRADOO-UHFFFAOYSA-N 0.000 description 1
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 238000012854 evaluation process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 229940094991 herring sperm dna Drugs 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000002796 luminescence method Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052752 metalloid Inorganic materials 0.000 description 1
- 150000002738 metalloids Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 230000004001 molecular interaction Effects 0.000 description 1
- 229910021421 monocrystalline silicon Inorganic materials 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002667 nucleating agent Substances 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000013464 silicone adhesive Substances 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00029—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor provided with flat sample substrates, e.g. slides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
- G01N35/028—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations having reaction cells in the form of microtitration plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00279—Features relating to reactor vessels
- B01J2219/00306—Reactor vessels in a multiple arrangement
- B01J2219/00313—Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
- B01J2219/00315—Microtiter plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
- B01J2219/00662—Two-dimensional arrays within two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00702—Processes involving means for analysing and characterising the products
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00029—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor provided with flat sample substrates, e.g. slides
- G01N2035/00099—Characterised by type of test elements
- G01N2035/00158—Elements containing microarrays, i.e. "biochip"
Definitions
- the present invention relates to devices for the parallel implementation of microarray experiments for the detection of specific interactions between probe and target molecules in a microtiter plate and to methods for producing such devices. Furthermore, the invention relates to the use of such devices in a method for qualitatitven and / or quantitative detection of specific interactions between probe and target molecules.
- Biomedical tests are often based on the detection of an interaction between a molecule present in a known amount and position (the molecular probe) and an unknown molecule to be detected or unknown molecules (the molecular target or target molecules) to be detected.
- the probes are stored in the form of a substance library on carriers, the so-called microarrays or chips, so that a sample can be analyzed simultaneously on several probes simultaneously (DJ Lockhart, EA Winzeler, Genomics, Gene expression and DNA arrays; , 405, 827-836).
- the probes are usually immobilized in a predetermined manner on a suitable matrix described, for example, in WO 00/12575 (see, for example, US Pat. No. 5,412,087, WO 98/36827) or synthetically produced (see, for example, US Pat. No. 5,143,854).
- the detection of an interaction between the probe and the target molecule is usually carried out as follows: After fixing the probe or the probes in a predetermined manner to a specific matrix in the form of a microarray, the targets are brought into contact with the probes in a solution and under incubated in defined conditions. As a result of the incubation, a specific interaction takes place between the probe and the target. The binding involved is significantly more stable than the binding of target molecules to probes that are not specific for the target molecule. To remove target molecules that have not been specifically bound, the system is washed or heated with appropriate solutions.
- Detection of the specific interaction between a target and its probe can then be accomplished by a variety of methods, which typically depend on the type of marker that has been introduced into target molecules before, during, or after the interaction of the target molecule with the microarray.
- markers are fluorescent groups, so that specific target-probe interactions with high spatial resolution and compared to other conventional detection methods, especially mass-sensitive methods, can be read fluorescence optically with little effort (A. Marshall, J. Hodgson , DNA chips: An array of possibilities, Nature Biotechnology 1998, 16, 27-31, G. Ramsay, DNA chips: State of the art, Nature Biotechnology 1998, 16, 40-44).
- nucleic acid libraries are by far the most important. These are microarrays on which deoxyribonucleic acid (DNA) molecules or ribonucleic acid (RNA) molecules are immobilized.
- DNA deoxyribonucleic acid
- RNA ribonucleic acid
- a labeled for example with a fluorescent group target molecule in the form of a DNA or RNA molecule to a nucleic acid probe of the Microarrays is that both target molecule and probe molecule are in the form of a single-stranded nucleic acid. Only between such molecules can an efficient and specific hybridization take place.
- Single-stranded nucleic acid target and nucleic acid probe molecules are generally obtained by heat denaturation and optimum choice of parameters such as temperature, ionic strength and concentration of helix destabilizing molecules. This ensures that only probes with almost perfectly complementary, ie mutually corresponding, sequences remain paired with the target sequence (AA Leitch, T. Schwarzacher, D. Jackson, IJ Leitch, 1994, In Vitro Hybridization, Spektrum Akade ⁇ mischer Verlag, Heidelberg Berlin Oxford).
- microarrays or chips are e.g. fixed in closed chambers, which have inlets and outlets for changing the liquids necessary for the washing steps and hybridization steps.
- closed chambers Such systems are e.g. in US 6,287,850 and WO 01/02094.
- DE 199 40 750 describes a carrier for analyte determination method which, after slight design changes for use in array applications, is also suitable for this invention.
- Sequence analysis of DNA typically uses surface-bound DNA libraries that are mounted on microscope slides. To carry out the hybridization reaction on these slides so far special hybridization chambers or incubation chambers are used. In order to ensure the temperature and the mixing of the hybridization solution in these previously known chambers, a specially adapted for the device used and therefore consuming and expensive equipment is required.
- WO 01/02094 describes a cartridge comprising a DNA chip.
- a PCR and a hybridization reaction can be performed on a DNA chip.
- WO 95/33846 describes a body with a depression into which a substrate with nucleic acid molecules of known sequence is incorporated on defined regions.
- the body has a closed cavity into which the sample liquid can be injected.
- the filling channels are sealed via septa and opened with suitable piercing cannulas to fill the body or the cartridge.
- the use of the cartridges described above also requires dedicated apparatus.
- US 5,856,174 describes a miniaturized integrated nucleic acid diagnostic device. This device allows the collection of one or more samples, their preparation and the subsequent performance of several sample analyzes. Such a device is used for automatically performing a DNA chip-based analysis by combining and miniaturizing all resulting steps on a cartridge. The provision of such a device is extremely complicated and expensive.
- US Pat. Nos. 5,545,531 and 5,874,219 describe processes for carrying out reactions with microarrays in parallel.
- the devices used include a multi-microarray wafer forming the bottom of a multi-well plate with a microarray in each well of the multi-well plate.
- the detection of the probe-target interactions on the arrays is carried out by reading the signals from fluorescent, light-scattering or radioactive labels.
- the design of a complete wafer as the bottom of a multi-vessel plate has the disadvantage that even a faulty array on the wafer leads to a faulty multi-vessel plate. Quality control of individual microarrays on the wafer is not possible.
- WO 04/065009 likewise describes a device for carrying out microarray processes in parallel.
- the device comprises a carrier with at least one reaction chamber in which biologically active molecules are immobilized.
- the reaction chamber has a ratio of bottom surface to wall height of at least 30 to 1.
- the detection can be carried out by various methods such as fluorescence, luminescence or spectroscopic methods.
- a disadvantage of the devices described in WO 04/065009 is the high technical complexity required for the detection, as well as the difficult handling of the device due to the volume enlargement means to be used.
- the present invention is therefore based on the object to provide a device for parallel implementation of array experiments, which is characterized by simple construction, easy handling and thus cost-effective production.
- a further object of the present invention is to provide a device for the parallel performance of microarray experiments that is compatible with common laboratory devices for the processing of microtiter plates and that allows the parallel execution of microarray-based tests while avoiding sources of contamination .
- an object of the present invention is a device for Implementation of array method provide that allows the use of detection methods with relatively little technical effort.
- a further object of the present invention is therefore to provide a device which ensures simple performance of microarray-based tests, in particular for diagnostic purposes. It is a further object of the present invention to provide standardized and possibly validated microarray-based tests that can be carried out in a simple manner regardless of the operator and the location of the test.
- a device for the parallel implementation of microarray experiments for the detection of specific interaction between probe and target molecules which has a microtiter plate, in whose wells each a single microarray with arranged on predetermined areas probe molecules is substantially continuously integrated.
- the devices according to the invention for the detection of specific interactions between molecular target molecules and probe molecules offer the significant advantage that it is not necessary to purchase additional devices or additional equipment for carrying out the detection reactions, since these are usually used in laboratories, in particular biological laboratories, equipment used for the handling of conventional microtiter plates, which are used for the parallel execution of medical or biological tests or reactions can be used.
- conventional devices for filling, moving or tempering microtiter plates with standard formats are compatible with the devices according to the invention.
- the arrangement of the microarrays in a microtiter plate allows the detection of the interaction reaction between target and probe molecules by conventional methods such as fluorescence detection or radiochemical methods. Be particularly advantageous, the application of absorption measurements has been found, as they are particularly inexpensive to perform.
- Such an absorption measurement can be carried out, for example, by using a catalytically controlled reaction in which a precipitate is formed in a site-specific manner at the surface regions on which an interaction reaction has also taken place.
- a detection device can be used which uses one or more light-emitting diodes of any emission wavelength as the light source and, for example, has a CCD camera for spatially resolved detection of the interaction reaction on the predetermined regions of the chip.
- a method of making a device for performing microarray experiments in parallel to detect a specific interaction between probe and target molecules on a microtiter plate comprising the following steps:
- microarrays with probe molecules arranged on predetermined regions of the microarray; b) checking the quality of the microarrays generated in step a); c) selecting suitable microarrays; and / or d) fixing the microarrays selected in step c) in wells of the microtiter plate.
- the method according to the invention for producing the devices for detecting biopolymers on microtiter plates has the significant advantage that it comprises carrying out a quality control and thus making it possible to select those microarrays or chips which meet the quality requirements.
- an apparatus for performing and analyzing microarray experiments to detect a specific interaction between probe and target molecules comprising: a microtiter plate, each microsray well in wells of predetermined areas of the microtiter plate Microarrays arranged probe molecules is integrated; and a detector device configured to detect a specific interaction between probe molecules and target molecules arranged on predetermined regions of the microarray.
- an apparatus for performing and analyzing microarray experiments to detect specific interaction between probe and target molecules comprising: at least one reaction vessel into which a microarray integrates probe molecules disposed on predetermined regions of the microarray is; a detector device configured to detect a specific interaction between probe molecules and target molecules arranged on predetermined regions of the microarray; a processing device configured to process the specific interaction detected by the detector device based on an externally selectively predeterminable, preferably validated, processing instruction.
- a method of processing a specific interaction between target molecules and probe molecules located on predetermined regions of a microarray, as determined by an array for performing and analyzing microarray experiments comprising detecting by a detector device specific interaction is processed based on an externally selectively predetermined processing instruction.
- a computer-readable storage medium incorporating a program for processing one by means of an array for performing and analyzing microarray experiments specific interaction between target molecules and probe molecules located on predetermined regions of a microarray, wherein the program, when executed by a processor, processes a specific interaction detected by a detector device based on an externally selectively predetermined processing instruction.
- a program element storing a program for processing a specific interaction between target molecules and probe molecules located on predetermined regions of a microarray detected by an array for performing and analyzing microarray experiments, wherein the program, when executed by a processor, processes a specific interaction detected by a detector device based on an externally selectively predetermined processing instruction.
- the present invention relates to the use of the above-described devices according to the invention and / or arrangements for the parallel execution of microarray experiments in a method for the qualitative and / or quantitative detection of the specific interaction between probe and target molecules, comprising the following steps:
- a microtitre plate is understood to mean a one-dimensional or two-dimensional arrangement or a grid of separate reaction vessels or wells or cavities or depressions on a plate, which is or are used for the parallel execution of biological, chemical and / or or laboratory tests or reactions.
- Microtiter plates according to the present invention have typical formats and dimensions of conventional microtiter plates, as are known to the person skilled in the art and, for example, from the manufacturers Nunc (Roskilde, Denmark,) Greiner Bio-One (Frickenhausen, Germany) or VWR International (Vienna, Austria). They are usually made of polycarbonate or polypropylene.
- the microtiter plates corresponding to so-called. 96well or 384well microtiter plates 8 x 12 or 16 x 24 wells.
- a conventional microtiter plate is shown in Figure 1.
- the external dimensions of the devices of the invention thus correspond to the usual standard for microtiter plates of about 127.76 mm x about 85.48 mm plate length x plate width with wall heights of the individual wells in the range of usually about 14 mm to about 14.5 mm, so that they with standard laboratory equipment for the handling of microtiter plates eg can be filled, moved and tempered.
- Typical filling volumes of the individual wells are, as is the case with standard microtiter plate formats, in the range from a few ⁇ l to a few 100 ⁇ l, depending on the degree of parallelism of the device according to the invention.
- the shape and geometry of the individual wells of the device according to the invention are, for example, cylindrical, conical or cuboidal, as in standard formats of microtiter plates and strips.
- the wells preferably have a planar bottom surface, which usually has a rectangular, square or circular basic shape.
- microtiter plate also includes so-called vascular strips or strips or ELISA strips.
- vascular strips or strips or ELISA strips Under such a vessel strip is in Within the scope of the present invention, a one-dimensional arrangement of, for example, eight or twelve, separate wells on a plate or a strip, as they are sold, for example, by the manufacturers Nunc and Greiner.
- a conventional vascular strip is shown in Figure 2.
- microarrays when the microarrays are integrated into wells of such a vascular strip, they may, like the conventional standard size and size strips, be housed in microtiter plate outer dimensions individually or in a microtiter plate consisting of up to twelve or more more strips are attached to process them with standard microtiter plate handling equipment. This allows the individual provision of a microtiter plate made of strips with probe arrays for various applications.
- a microarray or a probe array or a bioarray is understood to mean an arrangement of molecular probes or a substance library on a support, the position of each probe species being determined separately.
- the array comprises defined locations or predetermined areas, so-called array elements, which are particularly preferably arranged in a specific pattern, wherein each array element usually contains only one species of probes.
- the arrangement or immobilization of the molecules or probes on the support can be generated by covalent or non-covalent interactions.
- the probes are arranged on the reaction space to the interior of the wells facing side of the carrier. A position within the array, i. of the array is commonly referred to as a spot.
- a probe or a probe molecule is understood as meaning a molecule which is used for the detection of other molecules by a specific, characteristic binding behavior or a specific reactivity.
- the probes arranged on the array are suitable for any kind of molecules that can be coupled to solid surfaces and have a specific affinity.
- these are biopolymers, in particular biopolymers from the classes of the peptides, proteins, antigens, antibodies, carbohydrates, nucleic acids and / or their analogs and / or mixed polymers of the abovementioned biopolymers.
- the probes are particularly preferably nucleic acids and / or nucleic acid analogs.
- nucleic acids both DNA and RNA molecules can be used.
- the oligonucleotide probes may be oligonucleotides of 10 to 100 bases in length, preferably 15 to 50 bases, and more preferably 20 to 30 bases in length, immobilized on the array surface.
- nucleic acid molecules of defined and known sequence which are used to detect target molecules in hybridization methods, are referred to as probes.
- nucleic acids both DNA and RNA molecules can be used.
- the nucleic acid probes or oligonucleotide probes can be oligonucleotides with a length of 10 to 100 bases, preferably 15 to 50 bases and particularly preferably 20 to 30 bases in length.
- the probes are single-stranded nucleic acid molecules or molecules of nucleic acid analogs, preferably single-stranded DNA molecules or RNA molecules, which have at least one sequence region which is complementary to a sequence region of the target molecules.
- the probes may be immobilized on a solid support in the form of a microarray.
- they may be radioactively or non-radioactively labeled, so that they can be detected by a standard detection reaction in the art.
- a target or a target molecule is understood to be the molecule to be detected by a molecular probe.
- the targets to be detected are nucleic acids.
- the probe array according to the invention can also be used analogously for the detection of peptide / probe interactions, protein / probe interactions, carbohydrate / probe interactions, antibody / probe interactions, etc.
- the targets in the context of the present invention are nucleic acids or nucleic acid molecules that are detected by hybridization against probes arranged on a probe array
- these target molecules generally comprise sequences with a length of 40 to 10,000 bases, preferably from 60 to 2,000 bases, also preferably from 60 to 1,000 bases, more preferably from 60 to 500 bases, and most preferably from 60 to 150 bases.
- Their sequence optionally includes the sequences of primers as well as the sequence regions of the template defined by the primers.
- the target molecules may in particular be single-stranded or double-stranded nucleic acid molecules of which one strand or both strands are radioactively or not radioactively labeled so that they can be detected in one of the detection methods customary in the prior art.
- the target sequence according to the invention is the sequence region of the target, which is detected by hybridization with the probe. According to the invention is also spoken of that this area is addressed by the probe.
- a substance library is understood to mean a multiplicity of different probe molecules, preferably at least two to 1,000,000 different molecules, more preferably at least 10 to 10,000 different molecules, and most preferably between 100 and 1,000 different molecules.
- a substance library can also comprise only at least 50 or fewer or at least 30,000 different molecules.
- the substance library is preferably arranged as an array on a support in the reaction chamber of the device according to the invention.
- the arrangement of the substances or probe molecules on the carrier is preferably carried out in such a way that each substance or each species of probe molecules is assigned a specific, uniquely identifiable location and that each substance or species of probe molecules is immobilized separately from the others.
- an array element or a predetermined region or a spot or an array spot is understood to be an area on a surface intended for the deposition of a molecular probe; the sum of all occupied array elements is the microarray or the probe array.
- a carrier element or carrier or substance library carrier or substrate is understood to mean a solid body on which the probe array is constructed.
- the support which is commonly referred to as a matrix, may be e.g. to act microscope slides or wafers or even ceramic materials.
- Conventional arrays or microarrays in the context of the present invention comprise about 2 to 10,000, preferably 10 to 2,000 and particularly preferably at least 30 or at least 100 different species of probe molecules or biopolymers on a, preferably square, surface of, for example, 1 mm to 5 mm x 1 mm to 5 mm, preferably 2 mm x 2 mm or about 17.64 mm 2 .
- microarrays in the context of the present invention comprise about 50 to about 80,000, preferably about 100 to about 65,000, more preferably about 1,000 to about 10,000 different species of probe molecules in an area of several mm 2 to several cm 2 , preferably about 1 mm 2 to 10 cm 2 , more preferably about 2 mm 2 to about 1 cm 2, and most preferably about 4 mm 2 to about 6.25 mm 2 .
- a conventional microarray of from 100 to 65,000 has different species of probe molecules in an area of about 4.2 mm x about 4.2 mm.
- exemplary sizes of the surfaces of the microarray or the surfaces for the synthesis of the biopolymers are about 1 to 10 mm x about 1 to 10 mm, preferably about 2 to 5 mm x about 2 to 5 mm and particularly preferably about 3.5 to 4 , 5 mm x about 3.5 x 4.5 mm.
- a biochip array or a biochip microtiter plate is understood to mean an arrangement of bioarrays or microarrays on a microtiter plate or a vessel strip, the bioarrays being integrated in the wells of the microtiter plate or the vessel strip.
- the microtiter plate or the vessel strip of the device according to the invention is also referred to below as an array, microarray, bioarray or biochip carrier.
- a substantially continuous integration of a microarray into a well is understood to mean that the microarray is arranged in the well in such a way that the surface of the bottom or the side wall or the lid of the well is in contact therewith arranged microarray is substantially planar. Due to the fact that the microarray is substantially continuously integrated into the well, there are substantially no voids between the side walls of the microarray and the adjacent walls of the well, which may result from the fact that the base area of the microarray is smaller than that Base of the well on which the microarray is arranged before.
- a single microarray is understood to mean that only one substance library is arranged on the carrier of the microarray. That is, the Microarrays integrated into wells of a microtiter plate according to the invention have no coherent carrier. A separate microarray is thus integrated into a well. A single microarray is not connected to other microarrays via a common carrier.
- a marker in the context of the present invention denotes a detectable moiety, for example a fluorophore or an anchor group, to which a detectable moiety or a catalyst or crystallization seed catalyzing the reaction of a soluble starting material or substrate into an insoluble product can be coupled.
- an educt or substrate in the sense of an enzymatic substrate is understood to mean a molecule or a combination of molecules dissolved in the reaction medium, which or the one using a catalyst or a crystallization nucleus and / or a transposing Agent is deposited locally.
- the converting agent may, for example, be a reducing agent as in silver deposition or an oxidizing agent as in the production of a dye by enzymatic oxidation.
- the sample or sample solution or analyte is the liquid to be analyzed with the target molecules to be detected and optionally amplified.
- a replication reaction or an amplification reaction in the context of the present invention usually comprises 10 to 50 or more amplification cycles, preferably about 25 to 45 cycles, particularly preferably about 40 cycles.
- a cyclic amplification reaction in the context of the present invention is preferably a polymerase chain reaction (PCR).
- PCR polymerase chain reaction
- a molecular interaction or an interaction is understood in particular to mean a specific, covalent or non-covalent bond between a target molecule and an immobilized probe molecule.
- the interaction between probe and target molecules is a hybridization.
- Hybridization is the formation of double-stranded nucleic acid molecules or duplex molecules from complementary single-stranded nucleic acid molecules.
- the association preferably always takes place in pairs of A and T or G and C.
- An association may also preferably occur via non-classical base pairings such as wobble base pairings e.g. between inosine and G or inosine and C.
- base pairings such as wobble base pairings e.g. between inosine and G or inosine and C.
- duplexes can also be formed with nucleic acid analogs, e.g. DNA PN A duplexes, RNA PN A duplexes, DNA LNA duplexes and RNA LNA duplexes.
- Hybridization experiments are commonly used to detect sequence complementarity and thus identity between two different nucleic acid molecules.
- sample transfer in particular sample transfer, incubation, purification, concentration, labeling, amplification, interaction or hybridization and / or washing and rinsing steps, and more for the detection or understood method steps performed for the detection of targets with the aid of substance libraries.
- a validated test or a validated experiment is understood to mean a test, in particular microarray-based, which gives a defined result under the same conditions, for example the same temperature.
- an array layout is understood to mean the arrangement of the spots on an array, that is to say in particular the spatial distribution of the spots on an array, as well as possibly the arrangement and type of reference spots.
- the term allocation table refers to the allocation of the spots or the corresponding signals to the probe species arranged thereon, a correlation of spots or the corresponding signals to one another, e.g. understood the correlation of spots with probes directed against wild-type and mutant, and / or the assignment of the probe species or the corresponding signal to the question to be analyzed, in particular diagnostic.
- a threshold value table is understood from which measured value on a spot a signal is classified as a positive signal.
- a first subject of the present invention is therefore in particular a device for the parallel execution of microarray experiments for detecting a specific interaction between probe and target molecules, comprising a microtiter plate or a vascular strip with microarrays, wherein in wells of the microtiter plate or the vascular strip, respectively a single microarray with probe molecules arranged on predetermined regions of the microarray is substantially continuously integrated.
- a microarray is integrated in each well of the microtiter plate.
- embodiments are also conceivable in which one or more wells do not contain microarrays.
- the device according to the invention thus comprises an arrangement of standard reaction vessels or wells in the microtiter plate format.
- the device according to the invention differs from the conventional standard microtiter plates in that preferably in each well, a microarray with arranged on predetermined areas probe molecules for performing a molecular analysis is integrated.
- a microarray with probe molecules immobilized thereon on predetermined regions is also referred to below as a chip or affinity matrix.
- the predetermined areas on the carrier are also referred to below as array elements.
- the base area of a well on which the microarray or the support element is arranged or integrated with the probe molecules immobilized thereon on predetermined regions is usually the base of a well of the microtiter plate of the device according to the invention. If there are technical reasons, then the microarray or chip can also be installed or integrated in the sidewalls of a well.
- the microarrays are integrated in a cover device or a cover of the microtiter plate.
- a covering device is usually a separate unit with which the wells of the device according to the invention can be closed in a liquid-tight manner during certain reaction steps and the arrays in the cover can be brought into contact with the respective solution.
- the incorporation of the carrier element or the chip surface into a lid is particularly advantageous if the affinity matrix is sensitive to the conditions in one or more of the reaction steps for preparing and / or performing the detection reaction.
- Such reaction steps can be carried out in this embodiment of the device according to the invention in the upright device, whereby the affinity matrix or the chip does not come into contact with the reaction and sample solutions and thus protected.
- the device according to the invention is then rotated or placed on the lid, so that the sample comes into contact with the surface-bound probes. On in this way the thermal and chemical load on the affinity matrix or the chip is reduced.
- microarrays of the device according to the invention are integrated substantially continuously in the respective well, so that there are substantially no voids or no gaps or no free areas between the side walls of the microarray and the adjacent walls of the well.
- this is achieved in that the base area of a microarray to be integrated corresponds exactly to the base area of the well on which the microarray is fixed. In this way, the microarray can be accurately integrated into a well without causing unwanted voids on the sides of the microarrays.
- the base area of the microarray is smaller than the base area of the well on which the microarray is arranged.
- exemplary embodiments are described by way of which a continuous integration in such a case can be achieved.
- the substantially stepless integration can be achieved by fixing the microarray on a base of a well, respectively, and disposing a spacer between the microarray and the sidewalls of the well.
- a spacer may, for example, be a wedge or a ring or a curable compound which substantially completely fills voids between the microarray and the sidewalls of the well.
- the spacer is of an inert material to the reagents used in the detection reactions of the present invention, and preferably of the same material as the wells or microtiter plate.
- materials selected from the group consisting of glass, glass ceramic, plastic-coated glass and plastics or organic polymers such as elastomers, polypropylene, polyethylene, polystyrene, polycarbonate, PVC, polymethyl methacrylate, silicone plastic, rubber, polytetrafluoroethylene and / or nylon.
- plastics or organic polymers such as elastomers, polypropylene, polyethylene, polystyrene, polycarbonate, PVC, polymethyl methacrylate, silicone plastic, rubber, polytetrafluoroethylene and / or nylon.
- metals in particular stainless steels, platinum and / or aluminum, are conceivable as materials.
- the spacer is configured such that it substantially completely fills voids or spaces between the microarray and the sidewalls of a well.
- the wells each have a receptacle in which the microarrays are fixed.
- a receptacle or saving or opening is preferably prefabricated within the bottom or the bottom surface of a well. In this opening engages the respective microarray.
- the intervention is preferably positive.
- the wells each have a recess or an opening in which or in which the microarrays are fixed.
- the microarray can be fixed, for example, from the inside and / or from the outside.
- the device according to the invention has a typical shape and size for a microtiter plate and in the wells in each case a shaped as an enclosure breakthrough for receiving the microarrays or affinity matrices, in particular of surface-bound substance libraries.
- the microarrays are fixed in a breakthrough especially when the wells have a conical shape.
- microarrays are preferably adhesive, clicking, clamping and / or magnetically fixed in the wells.
- fixation by screws and / or welding, in particular by laser welding the microarrays.
- further types of attachment of the microarrays are conceivable.
- microarray or chip is also at higher internal pressure, e.g. when used in a centrifuge or when heating the sample liquid to temperatures near the boiling point, in the microtiter plate can not be pushed out of its attachment to the outside.
- Clamping or thread or grids have the advantage that provide a positive and liquid-impermeable connection between the well and carrier or chip.
- Such variants combine the advantages of inserting the carrier or chip from the inside into the reaction vessel with those of a simplified assembly.
- the vascular bodies of the device according to the invention in the form of a microtiter plate in standard formats, e.g. be produced by injection molding.
- the material of the microtiter plate or the wells corresponds to the materials commonly used for microtiter plates. Preferably, the materials become such selected that the devices of the invention behave thermally, mechanically and thermo-mechanically stable under typical conditions Christs ⁇ for molecular detection reactions.
- the material of the microtiter plate or the wells should also preferably not undergo any reactions with the materials and reagents commonly used in molecular tests, that is to say be chemically or biochemically inert.
- the material of the microtiter plate or the wells is for example selected from the group consisting of glass, glass ceramic, plastic-coated glass and plastics or organic polymers such as polypropylene, polyethylene, polystyrene, polycarbonate, PVC, polymethyl methacrylate, silicone plastic, rubber, polytetrafluoroethylene and / or nylon ,
- polypropylene and polyethylene are particularly preferred.
- the materials of the wells or microtiter plates into which the probe arrays are incorporated at least in the region of the base of the well on which the microarray is integrated, sufficiently transparent to an optical detection of interactions on the microarray, in particular by transmission measurements in the visible wavelength range to ensure.
- the wells of the microtiter plates has a typical size for standard microtiter plates.
- Typical filling volumes of a well are in the range of about 5 ⁇ l to about 350 ⁇ l, but may also be higher or lower in specific embodiments.
- the wells have particularly preferably a filling volume of 5 .mu.l to 100 .mu.l, which is customary for a standard microtiter plate in the 384er format, or a filling volume of 10 .mu.l to 350 .mu.l customary for a standard microtiter plate in the 96er format.
- Further preferred filling volumes of a well are about 50 ⁇ l, about 150 ⁇ l or about 250 ⁇ l.
- the microarrays are glued to the base, preferably the bottom, of the wells, wherein preferably in each well a microarray is fixed.
- the adhesive used for adhesively fixing a microarray on the base of a well preferably also substantially completely fills the voids between the microarray and the sidewalls of the well.
- the adhesive serves as a spacer between the microarray and the sidewalls of the well. In this way it is achieved that the detection surface of the microarray is integrated into a planar surface on the bottom of the well. The adverse carry over of analyte or washing solutions in the spaces between the microarray and the side walls of the wells is thus avoided.
- the adhesives used for this purpose preferably behave thermally, mechanically and thermomechanically stable under typical reaction conditions for molecular detection reactions.
- the material used for fixing the microarrays also preferably undergoes no reactions with the materials and reagents commonly used in molecular tests, so they are preferably chemically or biochemically inert.
- the adhesives in the inventive devices fixed by gluing, z. B. when they are glued to the bottom surface of a well, the adhesives are usually applied with commercially available dispensers.
- the adhesives used are preferably UV or UV-VIS curing adhesives, for example urethane acrylate such as NOA76 (Norland, New Jersey, USA) and Vitralit VBB-I (Panacol-Elosol, Germany) and modified acrylates such as Photobond 4496, Photobond 4436 and Photobond 4442 ( all from DeIo, Germany), and platinum crosslinking polydimethylsiloxanes such as Sylgard 182 or Sylgard 184 (Dow Corning, Midland, Michigan, USA).
- Adhesives such as silicone adhesive, polyurethane adhesive, epoxy resin adhesive, cyanoacrylate adhesive, acrylic adhesive and / or heating adhesive can be used.
- Suitable adhesives are one-component silicone, e.g. Elastosil E43 (Wacker-Chemie GmbH, Kunststoff, Germany), two-component silicone, e.g. Sylgard 182 and 184 (Dow Corning Corporation, Wiesbaden, Germany); Polyurethane resin, e.g. Wepuran VT 3402 KK (Lackwerke Peters GmbH & Co. KG, Kempen, Germany); Epoxy resins such as e.g. SK 201 (SurA Chemicals GmbH, Jena, Germany); and / or acrylates such as e.g. Scotch-Weld DP 8005 (3M Germany GmbH, Hilden, Germany).
- silicone e.g. Elastosil E43 (Wacker-Chemie GmbH, Kunststoff, Germany)
- Sylgard 182 and 184 Dow Corning Corporation, Wiesbaden, Germany
- Polyurethane resin e.g. Wepuran VT 3402 KK (Lackwerke Peters GmbH & Co
- an adhesive used for adhesive fixing of the microarrays in the wells and a spacer used for stepless integration of the microarray into the wells are made of different materials.
- the spacer and / or the adhesive used is an elastomer.
- Elastomers have the advantage that they are elastic and thus stresses in the fixation of the arrays are avoided.
- preferred elastomers are the aforementioned silicone elastomers.
- sealing materials in the fixation of microarrays in receptacles and / or recesses e.g. different rubbers such as silicone rubber and / or rubber materials and the like can be used.
- a microarray is fixed by clamping in an opening, for example, on the bottom of a well.
- This glue-free fixation is usually achieved by heating the material of the well. Due to the heating of the material, the opening becomes wider due to the coefficient of linear expansion of the material. Then that will be Microarray placed in the Auihahme or opening. By cooling and the resulting shrinkage of the material, the microarray is fixed.
- the device according to the invention contains a material having a high coefficient of linear expansion, in particular in the temperature range from 20 ° C. to 100 ° C., particularly preferably in the temperature range from 25 ° C.
- Examples of particularly suitable materials having a high coefficient of linear expansion are methyl methacrylate with a coefficient of linear expansion of 0.85 • 10 4 K -1 in the range of 25 ° C to 80 ° C and / or polycarbonate with a coefficient of linear expansion of 0.7 • 10 -4 K -1 in the range of 25 ° C to 80 ° ° C.
- the microarray to be integrated is magnetically fixed to a well.
- the surfaces forming the contact surfaces between the well and the microarray are designed magnetically.
- the microtiter plate is a linear array of eight to twelve wells or a two-dimensional array of arbitrary multiples thereof.
- the microtiter plate may be a two-dimensional array of 8 x 12 wells or 16 x 24 wells.
- the wells preferably have a rectangular, square and / or circular base.
- the individual wells of the device according to the invention preferably have a probe array or microarray for carrying out array experiments on the base ground surface.
- the size of the probe arrays used depends on the size and geometry of the wells of the device according to the invention. In the case of cylindrical corrugations, in a strip-shaped or two-dimensional arrangement, with a bottom diameter of, for example, about 6.5 mm, probe arrays having an edge length of about 4.5 mm ⁇ about 4.5 mm are preferably used. In an arrangement of 384 parallel wells in the form of a 24 x 16 well microplate and square bottom surface of the wells with a side length of about 3.6 mm preferably square probe arrays of an edge length of about 3 mm are used. Other preferred dimensions of the biochips are about 2 x 2 mm to 10 x 10 mm.
- the carrier element or the carrier for the probe molecules in the device according to the invention is optically transparent and / or non-fluorescent in the region of the detection surface.
- Detection area is to be understood as the area of the carrier element on which probe molecules are immobilized on predetermined areas.
- the probe molecules are applied directly to the carrier element without the carrier element comprising a further basic element.
- the probe molecules are applied to a preferably optically transmissive and / or non-fluorescent chip, which in turn is fixed to a base element, preferably at least in the chip defined detection region is optically transparent and / or non-fluorescent, is connected.
- the dimensions of the chip are smaller than the dimensions of the primitive. In this case, the chip carrying the probe molecules and the base together form the support member.
- the base surface opposite the detection surface of the carrier element is likewise optically transparent and / or non-fluorescent in the region corresponding to the detection surface.
- a probe array or microarray comprises a support that allows the formation of arrays of probes on its surface.
- a support can be made inter alia of materials selected from glass, filters, electronic devices, polymers, metallic materials, and the like. and / or any combination of these materials.
- the probe molecules are arranged on a rough or porous support surface.
- the carrier may e.g. have a porous membrane, are applied to the probes or in which they are embedded.
- Such a porous membrane may have a thickness of 100 nm to 5 ⁇ m, preferably 200 nm to 2 ⁇ m or 400 nm to 1 ⁇ m.
- the carrier element consists of optically transparent and / or non-fluorescent materials.
- Such materials are, for example, glass, Borofloat 33 (for example, available from Schott, Jena, Germany), quartz glass, monocrystalline CaF 2 (for example, available from Schott), monocrystalline silicon, phenylmethyl methacrylate, acrylic and / or polycarbonate.
- optically non-transmissive or optically impermeable materials such as conventional filter, ceramic, metal, metalloid and / or plastic materials for the carrier element or the chip are preferred.
- nylon membranes made specifically for DNA libraries can be used as support materials.
- optically impermeable material for the carrier element or the chip is silicon.
- optically non-transmissive carrier materials is particularly preferred if the detection of probe / target interactions on the array by performing dark field and / or reflection measurements and / or the light source is located above the Biochiplies.
- the immobilized probe molecules on the carrier element are a substance library.
- the substance libraries can be protein substance libraries, peptide substance libraries and nucleic acid substance libraries.
- Proteinsubstance libraries may in particular be antibody, receptor molecule and membrane protein libraries.
- Conceivable peptide libraries are in particular receptor ligand libraries, pharmacologically active peptide libraries and peptide hormone libraries.
- Nucleic acid substance libraries are in particular DNA and RNA molecule libraries.
- ribosomal DNA sequences of microorganisms may be particularly preferably applied to the carrier element.
- they may be nucleic acid substance libraries for SNP analysis.
- protein or nucleic acid substance libraries which allow so-called expression profiling.
- combinatorial substance libraries are applied to the carrier element so that they contact the sample space of the wells.
- the carrier element is thus preferably characterized in that it has on its surface a detection surface with a substance library.
- the carrier elements integrated in the device according to the invention are so-called DNA chips.
- a DNA chip is a DNA library bound, for example, on a glass surface, with unambiguous assignment of the DNA sequences to predetermined areas of the surface.
- the device according to the invention additionally comprises an optical system with a light source and a detector.
- the light source and detector are arranged on opposite sides of the microtiter plate.
- suitable light sources and detectors are described below.
- the device according to the invention is thus used in a detection method in which, as described above, the detection takes place via a reaction which leads to a precipitate on the array elements, on which an interaction between probes and targets has taken place. Due to the specific interaction of the sample or the target with the probes, interaction products form in the wells on some array elements of the microarrays integrated therein Precipitation. These interaction products have a different absorption coefficient than the pure substances. By appropriate reactions, this effect can be significantly enhanced as described below.
- the detection device preferably comprises a camera, in particular a CCD or CMOS camera or similar cameras, which usually records the entire area of the probe array.
- a camera in particular a CCD or CMOS camera or similar cameras, which usually records the entire area of the probe array.
- scanning methods for the detection device for reading out the device according to the invention can also be used.
- the detection device additionally comprises a lighting and imaging or readout optics.
- the device according to the invention additionally comprises at least one light source.
- a light source in the context of the present invention preferably ensures homogeneous illumination of a carrier of a microarray.
- the light source is selected from the group consisting of lasers, light-emitting diodes (LED), surface radiators and high-pressure lamps.
- light sources in the form of illumination arrays can also be used in the device according to the invention.
- a homogeneous illumination of the carrier can be ensured in this embodiment, for example, characterized in that the light source comprises a plurality of diffused light sources whose superposition results in a homogeneous illumination.
- diffuse-scattering LEDs which are arranged in the form of a matrix, allow homogeneous illumination at short distances from the sample.
- the homogeneity of the illumination can also be achieved by a corresponding structuring of the corrugated floors or of the cover, if present, of the device according to the invention. In this way, the corrugated floors or covers of the device according to the invention assume the function of a lens.
- the bottom of the chip carrier is preferably uniformly translucent.
- the light source required for the transmission detection is preferably arranged under the biochip support, while the detection module is arranged above the biochip support.
- the arrangement of lighting and detection module can also be reversed.
- the regions of the device according to the invention which are located in the optical beam path, consist of transparent to highly transparent materials of optical quality.
- plastics such as polypropylene or polyethylene are preferably suitable in strengths of e.g. 0.1 mm to 1 mm.
- both illumination and detection modules are above the biochip support, i. on the side of the Biochipmonas, which faces the reaction space, so the interior of the wells arranged.
- the wells furthermore have a planarity, which is sufficient for the preferably optical detection, of the base area on which the microarray is located. This ensures a simple and stray light-free optical detection from above or from below.
- the parts of the corrugated walls which are not in the vicinity of the probe array can also be made of colored or pigmented plastics, for example of black polypropylene. As a result, disturbing background signals can be prevented.
- a further aspect of the present invention relates to a method for producing a device for the parallel execution of microarray experiments for detecting a specific interaction between target and probe molecules on a microtiter plate whose wells each have a single microarray with probe molecules arranged on predetermined regions of the microarray comprising the following steps:
- microarrays with probe molecules arranged on predetermined regions of the microarray, preferably in a composite;
- step b) checking the quality of the microarrays generated in step a);
- step d) fixing the individual microarrays selected in step c) in wells of the microtiter plate;
- microtiter plate and individual microarrays are provided separately from each other and in a separate step to a device for the parallel implementation of microarray experiments combined, for example by the probe arrays are glued to a base of the well or reaction vessel.
- the advantage of the method according to the invention is that the bioarrays, preferably in combination, eg on a wafer, can be produced independently of the microtiter plate and thus of the biochip carrier. After production of the arrays, eg in a composite, a quality control of the arrays can be carried out, after which only those microarrays for the fixation or assembly in the microtiter plate are selected, which correspond to the criteria of quality control.
- the production process according to the invention has the advantage that a higher yield of defect-free biochip supports is achieved than in conventional processes in which the bioarrays either be prepared directly on the Biochiparmely or the microtiter plate or a wafer with multiple bioarrays serves as the bottom of a microtiter plate.
- step a) of the method according to the invention several microarrays, for example preferably at least 50, at least 100, at least 150 or at least 350, more preferably at least 114, at least 120 or at least 397 microarrays, in a composite, eg on a wafer, a glass plate or a Slide produced.
- the number of microarrays may be limited depending on the dimensions of the microarrays and the support plate, for example about 80 microarrays for a conventional slide and about 416 microarrays for a 119.5 mm x 75 mm glass plate.
- the quality control in step b) is performed with the microarrays in the composite, eg on the wafer.
- the microarrays selected in step c) are in the composite, eg on the wafer, and are separated for fixing in the wells or are released from the composite, eg by sawing out of the composite.
- the microarrays are preferably integrated in step d) of the production process according to the invention essentially steplessly in wells of the microtiter plate. The essentially stepless integration takes place in particular as described above for the device according to the invention.
- microarrays used in the context of the present invention with probes immobilized at defined locations can generally be produced or produced by conventionally known methods.
- DNA chips are preferably prepared by commonly used spotting methods or by special spatially resolved synthesis methods. Alternative methods such as synthesis methods via a light-guided DNA synthesis are also suitable for the preparation.
- Methods for producing probe arrays or chips, especially of DNA chips, are known to the person skilled in the art and described inter alia in DE 197 06 570, EP 0 969 918 and WO 98/36827.
- the probe arrays are produced by two principally different methods.
- separately synthesized probes for example oligonucleotides
- spotters which ensure the site-specific deposition of very small quantities of liquid, and are covalently or non-covalently linked thereto.
- the procedure works serially. Each spot is individually equipped with the probe.
- probe arrays are generated by site-specific in situ synthesis of the probes, for example the oligonucleotide probes. The synthesis takes place in parallel, for example on a wafer scale. Suitable reagents for activating the array surface or suitable protective groups for the probe synthesis on the array surface are known to the person skilled in the art.
- Immobilization of molecules on the array surface can be either specific or nonspecific. The specific immobilization requires a selectivity of the interaction of certain chemical functions of the molecule to be immobilized with the surface of the substrate.
- An example of a specific, non-covalent immobilization is the binding of biotin-labeled nucleic acid to a streptavitin-coated substrate.
- Amino-modified nucleic acids can be specifically immobilized via the reaction of the amino group with an epoxide, a carboxy function or an aldehyde.
- the immobilization is preferably carried out via a terminal phosphate group of the probe or of the monomer building block of a biopolymer probe on an aminated surface.
- Site-specific immobilization occurs through a variety of mechanisms and chemical functions and can be both covalent and non-covalent.
- An example of this is the immobilization of nucleic acids on a substrate surface modified with poly-L-lysine, but also the immobilization of chemically unmodified nucleic acids on epoxidized, aminated or with aldehyde-functional occupied substrate surfaces.
- the invention further provides an arrangement for performing and analyzing microarray experiments to detect a specific interaction between probe and target molecules.
- This arrangement comprises a microtiter plate, wherein in wells of the microtiter plate in each case a single microarray with on predetermined areas of the microarray arranged probe molecules, in particular as described above, is integrated.
- a detector device is arranged for detecting a specific interaction between probe molecules and target molecules arranged on predetermined regions of the microarray.
- an integrated analysis system in which the microtiter plate and the detector device are cooperatively provided. Hybridization events in the wells can be reliably detected by means of the detector device.
- the microtiter plate is designed such that the wells have substantially no surface topology orberichtur in the bottom region.
- the microtiter plate is designed as described above in the context of the description of the device according to the invention for the parallel execution of microarray experiments.
- the arrangement further comprises a processing device which is set up to process a specific interaction detected by the detector device on a microarray based on an externally selectively predeterminable, preferably validated, processing instruction.
- a processing or processing device can thus be specified externally, in particular by a user, a desired operating mode of the arrangement.
- the arrangement can be provided with the information under which experimental conditions (for example temperature, type of the microarray or substance to be used, type of wash and buffer solutions to be used, degree of multiplexing, array layout, allocation table, threshold table, Parameters for processing such as duration of the assay, etc.) one or more microarray experiments on the microtiter plate should be performed and / or analyzed.
- the arrangement can be provided as a processing instruction, the information which type by examining, for example, which particular selected examination to perform by the device is desired (for example, examining whether a patient whose blood sample is being tested suffers from disease A, B or C).
- a user-specific setting of a desired mode of operation of the device can be specified externally, fixed for all future investigations, or merely related to the next investigation.
- a user may, for example, insert a barcode-containing plug-in card into the array or the microtiter plate may be provided with a barcode, wherein the control information and / or the assignment, for example, to an assay in the barcode readable by the arrangement.
- Protocol or an array type which may be contained in the device or on a storage medium supplied by the user.
- the user may select a mode of operation of the device through a menu.
- a user typed on a keyboard a number combination in which a particular desired operating mode is coded. Based on such a code, a corresponding control routine can be found in the arrangement.
- the control routine associated with the user supplied control information can be uniquely located.
- a processing instruction can be understood to include externally the entire code to be executed for operating the arrangement in relation to a selected application. Then, from the outside of the arrangement, the entire control program is supplied, so that a storage of control code in the arrangement is unnecessary.
- the processing instruction can be understood as providing only a kind of password or address as a processing instruction from the outside, the user having the associated executable code for operating the arrangement relative to a selected application is then included in the arrangement itself in the form of a database / software bank. Then, from the outside of the arrangement, only the information is supplied, which control program is to be executed, wherein the actual control code is stored in the arrangement.
- the invention provides an arrangement for carrying out and analyzing microarray experiments for detecting a specific interaction between probe and target molecules, which arrangement has at least one reaction vessel into which a microarray is integrated with probe molecules arranged on predetermined regions of the microarray. Furthermore, the arrangement contains a detector device that is set up to detect a specific interaction between probe molecules and target molecules arranged on predetermined regions of the microarray. A processing device is configured for processing the specific interaction detected by the detector device based on an externally selectively predeterminable, preferably validated, processing instruction.
- reaction vessel is in particular designed as described in international patent application WO 03/059516, the contents of which are hereby expressly incorporated by reference.
- the reaction vessel has a typical shape and / or size for a laboratory reaction vessel, wherein a support element with probe molecules immobilized thereon on predetermined regions is arranged on one of its base surfaces.
- a support element with probe molecules immobilized thereon on predetermined regions is arranged on one of its base surfaces.
- Laboratory reaction vessels of a typical shape and size are understood in the context of the present invention to be reaction vessels which are usually used as disposable reaction vessels, in the standard version of 1.5 ml, in, in particular biological or molecular biological, laboratories. Such laboratory reaction vessels are also referred to as tubes and, according to the most important manufacturer, in particular as Eppendorf tubes or "Eppis” (Hamburg, Germany). Thus, laboratory reaction vessels with a typical shape and size of Eppendorf are offered as standard reaction vessels or safe-lock reaction vessels.
- reaction vessels from manufacturers such as Greiner (Frickenhausen, Germany), Millipore (Eschborn, Germany), Heraeus (Hanau, Germany) and BlOplastics (Landgraaf, Netherlands) as well as other manufacturers can be used which have a shape and size as is typical for laboratory reaction vessels, in particular Eppendorf. Examples of laboratory reaction vessels of a typical shape and size are shown in Figure 14. Under laboratory reaction vessels typical shape and size are not understood in the context of the present invention, in particular not round-bottomed flask or other flasks such as Erlenmeyer flasks, beakers or measuring cylinders.
- the reaction vessel preferably differs from the abovementioned laboratory reaction vessels in that a carrier element with probe molecules immobilized on predetermined regions is arranged on one of its base surfaces.
- a carrier element with probe molecules immobilized thereon on predetermined regions is also referred to below as a chip or affinity matrix.
- the predetermined areas on the carrier are also referred to below as array elements.
- the reaction vessel has a typical shape and / or size for a laboratory reaction vessel.
- the reaction vessel according to the invention thus has a rotationally symmetrical shape, in particular a cylindrical or substantially cylindrical shape.
- a conical shape deviating from the cylindrical basic shape is furthermore included, the taper preferably occurring in the direction of the affinity matrix.
- Typical shapes are also combinations of cylindrical or substantially cylindrical areas and conical areas (see, inter alia, Figures 14-18).
- a preferred reaction vessel in the context of the present invention is compatible, in particular, with conventional bench centrifuges, for example from manufacturers such as Eppendorf or Heraeus, ie the reaction vessel is preferably suitable for centrifugation in conventional bench centrifuges.
- Usual maximum outer diameter for standard laboratory reaction vessels and thus also for a preferred reaction vessel in the context of the present invention are in the range of 0.8 cm to 2 cm, preferably 1.0 cm to 1.5 cm and more preferably 1.1 cm to 1.3 cm. Further preferred outer diameters are up to 0.9 cm, up to 1.2 cm, up to 1.4 cm, up to 1.6 cm and up to 1.7 cm.
- the height of the preferred reaction vessel in the present invention is usually 1.5 cm to 5.0 cm, preferably 2.0 cm to 4.0 cm, more preferably 2.5 cm to 3.5 cm, and most preferably 2 , 8 cm to 3.2 cm. Further preferred heights are to 2.6 cm, to 2.7 cm, to 2.9 cm, to 3.0 cm, to 3.1 cm, to 3.3 cm and to 3.4 cm. In specific embodiments, the height may also be 1.0 cm or more.
- the preferred reaction vessel in the present invention is centrifuged in conventional benchtop centrifuges and can thus be used for example in conventional benchtop centrifuges such as a standard bench top centrifuge with Eppendorf standard rotor as well as in conventional racks and holders for reaction vessels such as a tube rack from Eppendorf ,
- Conventional pipettes or syringes such as Eppendorf variable volume and fixed volume pipettes may be used to introduce the sample to be examined and other reagents required to perform the detection reaction into the reaction vessel.
- a carrier element or carrier is understood to mean a solid body on which the probe array is constructed.
- the carrier element with the probes arranged thereon is also referred to below as a chip and, in specific embodiments of the present invention, may also comprise a basic element on which the actual chip is arranged.
- the carrier element can be arranged in the reaction vessel by simply being inserted or clamped into a laboratory reaction vessel, preferably by designing the chip surface in such a way that it can be accurately inserted or clamped in a laboratory reaction vessel, for example in its lid.
- a base of the laboratory reaction vessel is flattened so that the support member are mounted thereon can. If there are technical reasons, then the carrier or the chip can also be installed in the side walls of the reaction vessel according to the invention.
- the base area preferably the bottom of the laboratory reaction vessel, has a recess for receiving the carrier.
- the carrier or chip for example, glued from the inside and / or from the outside and / or clamped and / or screwed and / or welded, in particular by laser welding, and / or snapped.
- the reaction vessel has a typical shape and size for a laboratory reaction vessel and an aperture-shaped aperture for receiving the affinity matrices, particularly surface-bound substance libraries. Examples of such embodiments of the reaction vessel are given in Figures 15 to 18. In addition to the variants shown there are, of course, further combinations of the type of attachment of the carrier conceivable.
- the incorporation of the carrier or chip from the inside has the advantage that the carrier or chip is also at higher internal pressure, e.g. when used in a centrifuge or when heating the sample liquid to temperatures near the boiling point, in the reaction vessel can not be pushed out of its attachment to the outside.
- the installation requires more effort than the installation from the outside.
- Clamping or thread or grids ensure a positive and liquid-impermeable connection between the reaction vessel and the carrier or chip.
- Such variants combine the advantages of inserting the carrier or chip from the inside into the reaction vessel with those of a simplified assembly.
- a disadvantage is another connection point, eg the clamping connection and the higher number of components.
- it is customary to start from an injection-molded standard laboratory reaction vessel, in particular from one of the abovementioned manufacturers. This is capped at the bottom and then remelted in a specially designed device. Such a method is particularly suitable for smaller quantities. For large quantities, it is advisable to injection-mold the reaction vessel directly in one of the aforementioned embodiments.
- the base on which the carrier element is arranged with the probe molecules immobilized thereon on predetermined regions is the bottom of the reaction vessel according to the invention.
- the carrier can also be mounted in the lid of the reaction vessel as described above.
- the incorporation of the carrier element or the chip surface into the lid of the reaction vessel is particularly advantageous if the affinity matrix is sensitive to the conditions in one or more of the reaction steps for preparing and / or performing the detection reaction.
- Such reaction steps can be carried out in this embodiment of the reaction vessel in the upright reaction vessel, whereby the affinity matrix or the chip does not come into contact with the reaction and sample solutions and thus protected.
- the reaction vessel is then rotated or placed on the lid, so that the sample comes into contact with the surface-bound probes. In this way the thermal and chemical loading of the affinity matrix or of the chip is reduced.
- the carrier element of the reaction vessel as described above is preferably optically permeable and / or non-fluorescent in the region of the detection surface.
- the detection surface is to be understood as the region of the carrier element on which probe molecules are immobilized on predetermined regions.
- the probe molecules are applied directly to the carrier element without the carrier element comprising a further basic element.
- the probe molecules are applied to a preferably optically transmissive and / or non-fluorescent chip, which in turn is firmly connected to a base element which is preferably optically transparent and / or non-fluorescent at least in the detection region defined by the chip ,
- the dimensions of the chip are smaller than the dimensions of the primitive.
- the chip carrying the probe molecules and the base together form the support member.
- the base surface opposite the detection surface of the carrier element is also optically transparent and / or non-fluorescent in the region corresponding to the detection surface.
- a probe array according to the present invention comprises a support that allows the formation of arrays of probes on its surface.
- a support may be made of, among others, materials selected from the group consisting of glass, filters, electronic devices, polymers, metallic materials, and the like. as well as any combination of these materials.
- the material of the container of the reaction vessel corresponds to the materials usually used for laboratory reaction vessels and is for example selected from the group consisting of glass, glass ceramic, plastic-coated glass and plastics or organic polymers such as polypropylene, polyethylene, polystyrene, polycarbonate, PVC, polymethyl methacrylate, silicone plastic, rubber, polytetrafluoroethylene and / or nylon.
- plastics or organic polymers such as polypropylene, polyethylene, polystyrene, polycarbonate, PVC, polymethyl methacrylate, silicone plastic, rubber, polytetrafluoroethylene and / or nylon.
- metals in particular stainless steels, platinum and / or aluminum, are conceivable as materials.
- the reaction vessel as described above further preferably has a size typical of a laboratory reaction vessel. Typical fill volumes are in the range of 100 ⁇ l to 2.5 ml, but may also be higher or lower in specific embodiments. More preferably, the reaction vessel has a standard filling volume of up to 1.5 ml for a standard Eppendorf tube. Further preferred filling volumes are up to 0.4 ml, up to 0.5 ml, up to 0.7 ml, up to 1.0 ml or to 2.0 ml.
- a core aspect of an arrangement according to the invention is in turn the externally provided and selected from a number of possibilities predetermining the manner of controlling and / or the evaluation of an experiment by the processing device, which is based on the processing instruction.
- an interface device wherein by means of the interface device, the processing instruction is externally predetermined.
- an interface device may be a slot into which a medium containing the processing instruction (for example, a magnetic card or a bar code) may be inserted to supply the processing instruction to the device.
- a medium containing the processing instruction for example, a magnetic card or a bar code
- Such an interface device may alternatively be a keyboard or a touch screen, by means of which a desired processing instruction can be entered by a user.
- the interface device can also be a USB interface via which the processing instruction can be transmitted.
- the interface device may be a graphical user interface (GUI) for externally specifying the processing instruction by a user
- GUI graphical user interface
- Such a GUI may comprise, for example, a keyboard and a computer mouse, by means of which a desired operating mode can be set via a screen can.
- the interface device may be configured to receive and read an externally insertable storage medium in which the processing instruction is stored.
- a storage medium may be, for example, a floppy disk, a magnetic card, a contactless chip card, an RFID tag or a barcode-containing device.
- the detector device may comprise an optical detection device, in particular a camera for optically reading out a specific interaction.
- an electrical readout technique may also be employed which may be based, for example, on the change in the electrical properties (eg, impedance) of an analyte, which may change in the event of a hybridization event.
- the structure of the detection device can be designed in particular as described in international patent application WO 03/059516, the relevant contents of which are hereby incorporated by reference.
- the camera may be a charge coupled device (CCD) camera, i.e., a charge coupled device.
- CCD charge coupled device
- the camera may be manufactured in CMOS technology, more particularly as a monolithic integrated circuit fabricated in silicon technology. This allows miniaturization of the arrangement.
- the detector device may have imaging optics between the camera and the microarray.
- imaging optics may include one or more optical elements such as lenses, apertures, mirrors, beam splitters, etc., to ensure optimal imaging of sensor events onto the camera. As a result, the detection sensitivity of the device can be improved.
- the detector device can comprise a light source, wherein the light source can be set up in particular for homogeneous illumination of the microarray.
- a light source may be selected from the group consisting of a laser, a light-emitting diode (LED), a surface radiator and a high-pressure lamp.
- a liquid supply means for introducing a liquid may be provided in wells of the microtiter plate.
- a liquid supply device may be provided for introducing a liquid into the at least one reaction vessel.
- Such a liquid supply device may in particular be designed as a pipetting device which can supply and mix definable amounts of one or more liquids, e.g. to perform a hybridization or PCR reaction, or to deliver analyte fluid.
- Such liquid supply devices or liquid handling devices include, inter alia, dispensing and Aspiriervorraumen and storage containers for washing solutions, detection solutions and substrates, and the like.
- the storage containers can be tempered by a conventional method.
- the reservoirs are connected in particular by means of hoses with a preferably in xyz- direction moving Probenverteilarm or head, which takes over the parallel, eg with a multi-channel adapter, and / or serial sample distribution, for example, in individual wells of the microtiter plate device according to the invention.
- the sample distribution head is movable in less than three dimensions and carried out the movement in the remaining dimensions of microtiter plates and / or storage containers becomes.
- the sample distribution head may include a nozzle or air supply.
- (tempered) air or other suitable gas can be blown onto the arrays if a drying step is required.
- the liquid supply device preferably removes a defined and selectable liquid from usually more than one, possibly tempered, storage container stored liquids and transfers them into a corresponding well.
- a device for liquid removal may also be provided, which preferably discharges a defined and selectable liquid, in particular the entire liquid from a well and, if necessary, transfers it to a container, for example a waste container.
- a container for example a waste container.
- a temperature of each of the wells of the microtiter plate can be adjusted.
- a temperature adjusting unit may also be arranged to set a temperature in the reaction vessel.
- a temperature adjustment unit can additionally extend the functionality of the integrated system according to the invention for carrying out and analyzing an experiment. By targeting a temperature, the speed of physical, chemical, and biochemical reactions and interactions can be precisely specified and optimized.
- a conventional temperature control device for microtiter plates can be used, which preferably also allows temperature gradients and temperature levels and particularly preferably allows for the purposes of PCR temperature changes required.
- the detector device and / or the microarray (s) and / or the liquid supply device and / or the liquid discharge device and / or the temperature adjustment unit are or are in any predeterminable direction movable.
- Each of said components may be moved in any direction with respect to each other of the other components.
- the detection device can be moved relative to the microtiter plate in a plane parallel to the microtiter plate in order to scan the individual sensor fields two-dimensionally.
- the distance between the detection device and the microtiter plate can be changed by moving and thus adjusted to a desired value.
- the detector device is rigid and the microtiter plate is movable in a plane parallel to the detection device.
- the microtiter plate and / or the microarray (s), for example at a position between the wells or at one of the edges of the microtiter plate and / or the microarray (s), preferably contains a marker, for example one as described below detectable unit, a recess, a bore, a hole, in particular a through hole, a reflective element, a crosshair on a suitable background and the like.
- the marker ensures exact positioning of the microtiter plate and / or the microarray (s) relative to the detector.
- the positioning is preferably carried out stepwise, wherein in one step the position of the marker is first detected and then the detection result, the actual value, is compared with a desired value and, if necessary, a correction of the position of the microtiter plate and / or the microarray (s) relative to the detector.
- the detection of the marker element and the subsequent correction of the position of the microtiter plate and / or of the microarray (s) relative to the detector are preferably carried out automatically, for example controlled by means of suitable software.
- a specific interaction detected by means of a detector device is processed based on an externally selectively predetermined processing instruction.
- a computer-readable storage medium storing a program for processing a specific interaction between target molecules and probe regions located on predetermined areas of a microarray, as determined by an array for performing and analyzing microarray experiments, wherein the program it is executed by a processor, the method is performed with the features described above.
- a program element in which a program for processing a specific interaction between target molecules detected by means of an arrangement for carrying out and analyzing microarray experiments and probe molecules arranged on predetermined areas of a microarray is stored.
- the program when executed by a processor, the method is performed with the features described above.
- the method according to the invention can thus be carried out both by means of a computer program, i. software, as well as by means of one or more special electrical circuits, i. in hardware, or in any hybrid form, i. using software components and hardware components.
- a core aspect of this method is that a specific interaction detected by means of a detector device can be processed based on an externally selectively predetermined processing instruction.
- the method operates and controls an arrangement according to the invention such that the manner of operation the arrangement and the evaluation of the measured data can be set from the outside and selected from a plurality of options.
- Code for the method may be supplied to a user on a storage medium of the device, which then performs such a procedure.
- the user merely clearly identifies with the processing instruction which control program already contained on a storage medium of the arrangement is to be provided by providing an address, flag, identification number or other coding as a processing instruction which clearly indicates to the device to which Control program to be accessed.
- selective processing may be performed according to a selected one of a plurality of possible microarray experiments.
- the assembly may be capable of performing a number of different experiments (for example, a first experiment to examine a sample for disease A, a second experiment to examine a sample for disease B, and a third experiment to examine a sample for disease C).
- the processing instruction may contain the information which particular experiment is now to be performed (for example, the first experiment to examine a sample for disease A).
- selective processing and analysis may be performed according to at least one selected experimental parameter for the performed microarray experiment.
- the processing instruction may include experimentally settable parameters, for example, temperature, type of microarray or substance to be assayed, type of wash and buffer solutions to be used, degree of multiplexing, array layout, allocation table, threshold table, parameters for processing such as duration of time Assay, etc, pretend.
- selective validated processing may be performed according to a specific microarray experiment. Under validated is understood in particular that in multiple execution of a particular experiment under the same conditions in each case the same result is obtained.
- the provision of the inventive arrangements enables (i) a standardized development of microarray-based assays, i. (Ii) a standardized validation of microarray-based tests, (iii) a simple execution or handling of a possibly, validated microarray-based test, in particular at arbitrary locations, and / or (iv) the performance an unlimited number of, possibly validated, microarray-based tests on a device.
- the arrangements are freely programmed and a software evaluation is carried out manually.
- a test-specific data record with the parameters for processing or processing and evaluation or analysis of the array or Created experiments.
- the developed data set is preferably validated together with the chemicals used, microarrays, in particular in the microtiter plate format according to the invention, assay conditions, etc.
- the data set preferably validated, is usually transferred once to the arrangement according to the invention, e.g. by means of a memory chip, if necessary with USB connection.
- the arrangement according to the invention preferably stores this data record in a database.
- the, preferably diagnostic, test can be carried out.
- the implementation is preferably carried out automatically.
- the arrangement preferably recognizes by means of an identification number of the microarrays used, preferably in the microtiter plate format according to the invention, which data record it requires to carry out the array test.
- a kit as mentioned above may in particular comprise hybridization buffers such as e.g. 6xSSPE, 2xMES, 3DNA and / or PBS; Blocking reagents such as e.g. Casein, milk powder, fetal calf serum, herring sperm DNA, these reagents preferably being dissolved in a suitable buffer; Wash buffer, e.g. 2xSSC with SDS or Triton, 2xSSC, 0.2xSSC and / or PBS; Enzyme buffers such as the above hybridization buffers; Enzyme substrate solutions such as e.g. TMB in a suitable buffer, e.g. Citrate buffer, for the enzymatic precipitation of an organic molecule and / or a silver solution for the silver precipitation of an inorganic precipitate; PCR master mixes; Sample preparation solutions; Denaturing solutions and / or renaturation solutions include.
- hybridization buffers such as e.g. 6xSSPE, 2xMES, 3DNA and / or
- the arrangements according to the invention make it possible by the combination of hardware, software, microarrays, preferably in the microtiter plate format according to the invention, to perform complex multi-parameter analyzes, in particular diagnostic analyzes, automatically.
- the arrangements according to the invention take over the tasks of sample multiplexing, the assignment of analyte data to result data, eg from patient data to diagnoses, the processing of the samples and / or the fully automatic evaluation.
- the arrangements according to the invention can process an unlimited number of different analytical, in particular diagnostic, questions.
- the arrangements according to the invention automatically recognize the question to be processed on the basis of an identification number, such as a barcode, of the microarray or of the microtiter plate according to the invention with microarrays arranged therein and carry out the analysis accordingly.
- an identification number such as a barcode
- the number of questions can be extended without restriction.
- the inventive arrangements can of course also be operated manually for the development of tests, in particular diagnostic tests.
- the microarrays or the device according to the invention comprising a microtiter plate with microarrays integrated therein are identified by an identification number (ID).
- ID an identification number
- the protocol for processing the associated test is loaded into a database.
- the protocol includes, for example, specific input parameters for the test; the degree of multiplexing; the directory of the surface-bound substance library, i. the array layout; an allocation table and / or a threshold table.
- specific input parameters e.g. Durability data of the hybridization and washing solutions, batch numbers, patient ID, dilutions and the like understood.
- Part of these specific input parameters can also be stored in a database.
- the reservoir of the washing solutions can be equipped with a barcode. This is read out when setting in the device, read out the corresponding record from a database and utilized.
- the software of the arrangement according to the invention is preferably able to link the data of the patient samples, preferably on a patient sample plate, with the data of a microarray or the device according to the invention comprising a microtiter plate with microarrays integrated therein and thus errors in the assignment of Test results to prevent patient samples. This can be done by reading an ID on the patient specimen plate or by manual input.
- a PCR reaction each with a specific set of primers for the genotypes HLA A, B, C, D, DR and DQ performed.
- the analysis of the PCRs is then carried out in a well of a microtiter plate according to the invention with microarrays integrated therein, which contains a microarray for the parallel analysis of all five genotypes.
- the assignment of the five wells of the PCR microtiter plate, each with a monoplex PCR to a multiplex analysis in a well of the microtiter plate according to the invention is realized via a corresponding assignment table.
- the wells of the microtiter plate, each with integrated microarrays are preferably guided sequentially over an imaging evaluation unit.
- the gray values are preferably automatically analyzed by software and evaluated on the basis of an assignment and threshold value table.
- the results are made available to the user and, if necessary, can be sent to a laboratory information management system (LIMS) via standardized interfaces.
- LIMS laboratory information management system
- any number of tests can be adopted in the arrangement according to the invention.
- the database may e.g. be supplemented via a so-called USB stick or via the Internet. In this way test can also be modernized or extended.
- the respective conditions can be traced for each test performed.
- the arrangement 1000 contains a microtiter plate 1001, wherein in wells 1002 of the microtiter plate 1001, a single microarray 1003 with probe molecules 1004 arranged on predetermined regions of the microarray 1003 is integrated in each case.
- a CCD camera 1005 is provided as a detector device and configured to detect a specific interaction between probe molecules 1004 and target molecules (not shown) disposed on predetermined regions of the microarray 1003.
- the assembly 1000 further includes processing means configured as a microprocessor 1006 ("central processing unit", CPU) adapted to process the specific interaction detected by the CCD camera 1005 based on an externally selectively presettable validated processing instruction Arrangement 1000 and processes detected signals based on the later described in more detail user or factory provided processing instructions.
- processing means configured as a microprocessor 1006 ("central processing unit", CPU) adapted to process the specific interaction detected by the CCD camera 1005 based on an externally selectively presettable validated processing instruction Arrangement 1000 and processes detected signals based on the later described in more detail user or factory provided processing instructions.
- CPU central processing unit
- the processing instruction is provided to the arrangement 1000 by means of a magnetic card 1007, which magnetic card 1007 is inserted into a magnetic card plug-in device 1008 as an interface device.
- a magnetic card 1007 On the magnetic card, an identification number is stored, which reads out a magnetic card readout device 1009.
- This identification number is supplied to the CPU 1006, which determines an operation program identified therewith stored on a hard disk 1010.
- the CPU 1006 accesses and, based on information contained therein, analyzes the data measured by the CCD camera 1005. Further, the CPU 1006 may control the experimental flow of the experiment and the conditions of the experiment by means of the relevant operation program.
- the detector device has an imaging optics between the CCD camera 1005 and the microarray 1003 in the form of a converging lens 1011.
- the detector device further comprises a light emitting diode 1012 as a light source for substantially homogeneous illumination of the microarrays 1003. Furthermore, a pipetting device 1013 which can be controlled by means of the CPU 1006 is provided as a liquid supply device for introducing a liquid into wells 1002 of the microtiter plate 1001.
- a thermostatting unit 1014 controllable by means of the CPU 1006 is provided, integrated in a receiving device 1015 for receiving the microtiter plate 1001.
- the thermostating unit 1014 is arranged to set a temperature of each of the wells 1002 of the microtiter plate 1001. This setting is made based on the processing instruction.
- the CCD camera 1005 is movable. Furthermore, the pipetting device 1013 can be moved by means of the movement device 1016.
- the reader 1009 reads out a processing instruction from the magnetic card 1007.
- the CPU 1006 controls the tempering means 1014 and the pipetter 1013 based on this externally selectively provided information to perform an experiment according to the processing instruction. Measurement data acquired by the CCD camera 1005 is then evaluated by the CPU 1006 according to the processing instruction.
- a further aspect of the present invention relates to the use of a device according to the invention or the above-described arrangements according to the invention as described above in a method for detecting the specific interaction between molecular probe and target molecules, comprising the following steps:
- the target molecules to be detected are provided with a detectable marker.
- the detection in the method according to the invention is thus preferably carried out by providing the bound targets with at least one label which is detected in step b).
- the label coupled to the targets or probes is preferably a detectable entity or a detectable entity coupled via an anchor group to the targets or probes.
- the method according to the invention is extremely flexible.
- the method of the invention is compatible with a variety of physical, chemical or biochemical detection methods.
- the only requirement is that the unit or structure to be detected can be coupled directly to a probe or a target, for example an oligonucleotide, or linked via an anchor group which can be coupled to the oligonucleotide.
- the detection of the label may be based on fluorescence, magnetism, charge, mass, affinity, enzymatic activity, reactivity, a gold label and the like. based.
- the label is preferably based on the use of fluorophore-labeled structures or building blocks.
- the label may be any dye that can be coupled to targets or probes during or after their synthesis. Examples include Cy dyes (Amersham Pharmacia Biotech, Uppsala, Sweden), Alexa dyes, Texas Red, fluorescein, rhodamine (Molecular Probes, Eugene, Oregon, USA), lanthanides such as samarium, ytterbium and europium (EG & G, Wallac, Freiburg, Germany).
- fluorescence markers in the context of the present invention, as a label or as a detection unit, which is coupled to the targets or probes, luminescence Markers, metal markers, enzyme markers, radioactive markers and / or polymeric markers.
- a nucleic acid can be used as tag (Tag), which can be detected by hybridization with a labeled reporter (sandwich hybridization).
- Tag can be detected by hybridization with a labeled reporter (sandwich hybridization).
- Use for detection of the tag find various molecular biological detection reactions such as primer extension, ligation and RCA.
- the detectable unit is coupled via an anchor group with the targets or probes.
- anchor groups are biotin, digoxygenin and the like.
- the anchor group is reacted in a subsequent reaction with specific binding components, for example streptavidin conjugates or antibody conjugates, which are themselves detectable or trigger a detectable reaction.
- specific binding components for example streptavidin conjugates or antibody conjugates, which are themselves detectable or trigger a detectable reaction.
- the conversion of the anchor groups into detectable units can take place before, during or after addition of the sample comprising the targets or, if appropriate, before, during or after the cleavage of a selectively cleavable bond in the probe.
- Such selectively cleavable bonds in the probes are e.g. in International Patent Application WO 03/018838, the content of which is incorporated herein by reference.
- the labeling according to the invention can also be effected by interaction of a labeled molecule with the probe molecules.
- the labeling can be carried out by hybridization of an oligonucleotide labeled as described above with an oligonucleotide probe or an oligonucleotide target.
- the bound targets are thus provided with a label which catalyzes the reaction of a soluble substrate or educt to a sparingly soluble precipitate on the array element on which a probe / target interaction has occurred or which acts as a nucleation agent for the conversion of a soluble substrate to a sparingly soluble precipitate on the array element where probe / target interaction has occurred.
- the optical detection of probe / target interactions is preferably carried out by recording modulations of certain optical parameters, in particular transmission, reflection, scattering, diffraction and interference.
- the detection of the presence of a precipitate on an array element in one embodiment of the present invention is accomplished by reflection, absorption or diffusion of a light beam, preferably one Laser beam or a light emitting diode, by the precipitation. Due to a granular form, the precipitate modifies the reflection of a light beam. Furthermore, the precipitate leads to a strong diffusion of light, which can be recorded by conventional detection devices. If the precipitate such as a silver precipitate or an organic precipitate appears as a dark surface, the absorption of light can also be detected and recorded.
- detection of the areas enhanced by the specific reaction can be accomplished by means of a simple optical setup in transmitted light, i. Contrast by shading, or incident light, i. Contrast by reflection), done.
- the detected intensity of the shaded area is directly proportional to the coverage with marks such as gold particles or enzymes and the nucleation state of the particles.
- the detection of precipitate formations on the detection surface or the support in the dark field i. Changes in the scattering properties of the detection surface or of the carrier are detected.
- a pre-amplification of the material to be analyzed is not required.
- targeted subregions can be amplified by means of PCR (polymerase chain reaction), in particular in the presence of the device or substance library carrier according to the invention as described in DE 102 53 966 and hybridized to the carrier. This represents a significant simplification of the workload.
- Example 1 Production of a device according to the invention for the parallel execution of microarray experiments
- transparent 8-well ELISA strips ie strips with eight interconnected individual vessels
- Greiner Bio-one item No. 762070
- the base area has a diameter of approx. 6.5 mm.
- Each of the eight wells of the array has its own probe array.
- the probe arrays inserted into the individual wells with cylindrical geometry have outer dimensions of 4.5 mm x 4.5 mm with an active area of 4.2 mm x 4.2 mm occupied by the respective substance library (see Figure 3).
- the introduction of the eight probe arrays in the individual wells of the device succeed by positionally accurate sticking to the bottom surface of the wells.
- a small amount of NOA76 adhesive (Norland, New Jersey, USA) is applied to the non-active side of the array support using a compressed air syringe that allows the finest dosing.
- the arrays are placed in the well and pressed for 3 s.
- the AT strip produced in this way is used for further fixing of the probe arrays with the bottom surface of the wells 7 s with light having a wavelength of approximately 300 to 450 nm (eg SoI 2, Dr. Hoenle AG, Germany; Filter filtered) hardened.
- the free surfaces between the biochip and the wall of the well are filled up with NOA76 adhesive and again hardened for 1 min under the action of light as described above.
- the finished AT-Strips can be used in standard 127,76 mm x 85,48 mm microplate frames (eg Greiner, Bio-one), which allow easy handling of the strips in standard microtiter plate devices. Twelve of the 8-well AT-strips fit into such a standard microtiter plate frame (see Figure 4).
- Example 2 Serological test with a device according to the invention for the parallel execution of microarray experiments
- the arrays of the inventive strips in this example consist of a library of antibodies in an array of 19x19 spots;
- the library consists of two different antibodies (human IgG and anti-human IgG), each containing nine different concentrations, three control antibodies and the biotin marker molecules required for evaluation and analysis.
- Antibodies and label molecules are applied by means of a needle-spotting method to a glass substrate surface in standard format standard slide, the antibodies are in a 20 mM trehalose provided PBS buffer.
- the spotting process ensures the parallel production of up to 80 individual glass chips on the re ⁇ carrier. After spotting, the glass substrate is singulated into 80 individual 4.5 mm x 4.5 mm chips with a ready-to-use antibody library on each chip.
- the strips are subjected to an ELISA-like test.
- the antibody libraries are first incubated with a primary antibody (human serum), washed and then mixed with a secondary antibody which is also biotin-labeled.
- a streptavidin-horseradish peroxidase conjugate is incubated and a TMB solution added.
- the specific interaction of the primary antibody with all surfaces of the probe array with anti-human IgG and binding of the secondary biotinylated antibody to the primary can be determined by a precipitate detection method detect with HRP horseradish peroxidase // TMB a specific array pattern with precipitate at the sites of human IgG.
- FIG. 1 An exemplary photograph of a TMB-stained chip as described above in a well of an array strip is shown in FIG.
- an array strip is used for a serological, ELISA-like test.
- the microarrays in the individual wells of the array strip contain a library of immobilized antibodies in an array of 19x19 spots;
- the library consists of two different antibodies (human IgG and anti-human IgG) in nine different concentrations and biotin marker molecules.
- the procedure of the assay consists first in the incubation of the bioarrays with human serum.
- the IgG contained in the human serum binds against the immobilized on the array anti-human IgG.
- a biotinylated secondary antibody which in turn binds to human IgG, is reacted with the biochip. This antibody binds both against the human IgG immobilized on the array and against the human IgG bound to the anti-human IgG.
- a streptavidin-horseradish peroxidase conjugate is added.
- This conjugate in turn, binds to the biotin label of the markers on the array as well as the second antibody. Subsequently, with the help of an enzymatic catalyzed reaction at the sites where the conjugate has bound, a precipitate precipitated, which in turn is documented by image acquisition.
- the procedure of the assay is described in more detail below.
- test procedure is automated using the device according to the invention for all 8 wells of the array strip:
- the two in the inventive device located tip blocks each filled with 96 pipette tips (Cybio AG, Jena, Germany).
- the other reagents required for the assay are blocking buffer (PBS-0.01% Tween with 2% BSA (Sigma, Germany)), the final stock solution of the biotinylated secondary antibody (goat-anti-human IgG, B-1140, Sigma, Germany, dilution 1: 10,000), the finished stock solution of the conjugate (poly-HRP, N200, Pierce, Germany, dilution 1: 10,000), the ready-to-use TMB staining solution (TrueBlue, KPL, USA) and the required washing buffer PBS (155 mM NaCl , 3.77 mM NaH 2 PO 4, 17.75 mM Na 2 HPO 4, pH 7.4) and PBS-0.01% Tween are introduced into the appropriate wells of the DeepWell plates (eg UNIPLATE 10000, 734-2558, VWR, Germany) in the device.
- PBS-0.01% Tween are introduced into the appropriate wells of the DeepWell plates (eg UNIPLATE 10000, 734-2558, VWR, Germany
- the PC unit will generate a list of occupied positions in the master plate containing the samples, here human serum.
- Conditioning picking up a pipette tip and serial filling of all 8 wells of the array strip with 200 ⁇ l each of the washing buffer PBS-0.01% Tween. Wash the array strip for 5 min at 23 ° C under agitation.
- Blocking reaction Take up a pipette tip and serially fill 8 wells of the array strip with 100 ⁇ l each of the blocking buffer. Incubate for 5 min at 23 ° C with agitation.
- Secondary Antibody Incubation Pick up a pipette tip and serially fill all 8 wells of the array strip with 100 ⁇ l each of the secondary antibody. Incubate for 30 min at room temperature with agitation.
- Conjugation Acquisition of a new pipette tip and filling of all 8 wells of the array strip with 100 ⁇ l of the streptavidin-horseradish peroxidase conjugate. Incubate for 30 min at 30 ° C with agitation.
- the present example uses an array strip for a genotyping assay to determine a patient's genetic predisposition to thrombosis.
- the microarrays in the individual wells of the array strip contain a library of immobilized oligonucleotides in an array of 19x19 spots; the library consists of a set of 12 different probes for genotyping, each 12-fold redundant, 2 control probes (also 12-fold redundant) as well as biotin marker molecules. All oligonucleotides are purchased from Ogham Diagnostics, Weg, Germany. Figure 11 shows the assignment of the array.
- the assay consists of first incubating the bioarrays in the array strip with biotinylated perfect-match oligonucleotides in a suitable buffer.
- the biotinylated oligos bind to the corresponding probes of the bioarray according to their sequence.
- a streptavidin-horseradish peroxidase conjugate is added. This conjugate binds to the biotin label of the markers on the array as well as to the biotinylated oligos attached to the bioarray.
- a precipitate precipitated which in turn is documented by an image acquisition.
- test procedure is automated using the device according to the invention for all 8 wells of the array strip analogously to Example 1:
- the two in the inventive device located tip blocks each filled with 96 pipette tips (Cybio AG, Jena, Germany).
- An appropriate array strip is placed in a commercially available microplate frame (for example, Greiner Bio-one) and placed in the designated position of the device.
- a commercially available microplate frame for example, Greiner Bio-one
- Blocking buffer 2xMES 200 mM MES, 2M NaCl, 40 mM EDTA, 0.1% cetyldimethylethylammonium bromide
- 2% milk powder 20% mM MES, 2M NaCl, 40 mM EDTA, 0.1% cetyldimethylethylammonium bromide
- the final stock solution of the conjugate poly-HRP, N200 , Pierce, Germany, dilution 1: 10,000 in 2xMES
- the ready-to-use TMB staining solution (TrueBlue, KPL, USA)
- the required washing buffer 2xSSC 0.3M NaCl, 0.03M Na citrate, ⁇ H7.0
- 2xSSC 0.01% Triton and 0.2xSSC are placed in the respective wells of the DeepWell plates (eg UNIPLATE 10000, 734-2558, VWR, Germany) in the device.
- the PC unit creates a list of occupied positions in the master plate containing the samples.
- Staining Add 100 ⁇ l of the TMB staining solution. Incubate for 10 min at RT.
- Figure 1 shows a conventional microtiter plate.
- Figure 2 shows a conventional vessel strip.
- Figure 3 shows a detail of the arrangement of chips in wells of a vessel strip or Elisa strip.
- Figure 4 shows a standard microplate frame with ten 8-well AT strips.
- Figure 5 shows a modified AT reader with linear guide module (CLONDIAG chip technologies GmbH, Jena, Germany).
- Figure 6 shows the image of a tetramethylbenzidine-stained chip in a well of an array strip.
- FIG. 7 shows an arrangement for carrying out and analyzing microarray experiments for detecting a specific interaction between probe and target molecules according to one exemplary embodiment of the invention.
- Figure 8 shows the assignment of the microarrays in the wells of the array strip according to Example 3.
- Figure 9 shows an exemplary photo of a well of the array strip according to Example 3 after the reaction.
- Figure 10 is an illustration of the result of an assay according to Example 3.
- Figure 11 shows the assignment of the microarrays in the wells of the array strip according to Example 4.
- Figure 12 shows an exemplary photo of a well of the array strip according to Example 4 after the reaction.
- Figure 13 is an illustration of the result of an assay according to Example 4.
- Figure 14 shows a photograph of two standard reaction tubes made of polypropylene with a filling volume of 1.5 ml.
- Figure 15 shows an embodiment in which in the bottom of a reaction vessel (2) has an opening or a recess (8) is incorporated with a bearing surface (6) on which the affinity matrix (100) can be placed from the outside.
- the affinity matrix (100) is bonded by placing the adhesive in a suitable adhesive tape (7).
- FIG 16 shows an embodiment in which in the bottom of a reaction vessel (2) has an opening (10) is incorporated with a support surface (11) on which the affinity matrix (100) can be placed from the inside.
- the affinity matrix (100) is bonded by placing the adhesive in a designated adhesive tape (9).
- Figure 17 shows an embodiment in which the bottom of a reaction vessel (2) is provided with a clamping connection (201). On this clamp connection (201), a chip carrier (200) can be pressed liquid-tight.
- the chip carrier has an opening (10) into which the affinity matrix (100) can be placed on a support surface provided for this purpose and then glued.
- the affinity matrix (100) between the reaction vessel (2) and a clamping sleeve (300) is clamped liquid-tight, so that a bond is not absolutely necessary.
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10179918.7A EP2305383B1 (en) | 2004-11-09 | 2005-11-09 | Devices for carrying out and diagnosing microarray experiments |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004054094 | 2004-11-09 | ||
DE102004056735A DE102004056735A1 (en) | 2004-11-09 | 2004-11-24 | Device for performing and analyzing microarray experiments |
PCT/EP2005/055871 WO2006051088A2 (en) | 2004-11-09 | 2005-11-09 | Devices for carrying out and diagnosing microarray experiments |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10179918.7A Division EP2305383B1 (en) | 2004-11-09 | 2005-11-09 | Devices for carrying out and diagnosing microarray experiments |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1807209A2 true EP1807209A2 (en) | 2007-07-18 |
Family
ID=35781453
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05813339A Withdrawn EP1807209A2 (en) | 2004-11-09 | 2005-11-09 | Devices for carrying out and diagnosing microarray experiments |
EP10179918.7A Revoked EP2305383B1 (en) | 2004-11-09 | 2005-11-09 | Devices for carrying out and diagnosing microarray experiments |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10179918.7A Revoked EP2305383B1 (en) | 2004-11-09 | 2005-11-09 | Devices for carrying out and diagnosing microarray experiments |
Country Status (5)
Country | Link |
---|---|
US (1) | US20080207461A1 (en) |
EP (2) | EP1807209A2 (en) |
DE (1) | DE102004056735A1 (en) |
HK (1) | HK1156274A1 (en) |
WO (1) | WO2006051088A2 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004056735A1 (en) | 2004-11-09 | 2006-07-20 | Clondiag Chip Technologies Gmbh | Device for performing and analyzing microarray experiments |
JP2007156431A (en) * | 2005-11-11 | 2007-06-21 | Olympus Corp | Microscope system |
BRPI0814582B1 (en) | 2007-07-23 | 2021-05-11 | Clondiag Gmbh | method, and use of the total viral load in an untreated whole blood sample |
DE102008057067A1 (en) | 2008-11-13 | 2010-05-20 | BF-BIOlabs Schneider und Zeltz GbR (Vertretungsberechtigten Gesellschafter: Dr. Patric Zeltz 79211 Denzlingen und Stephan Schneider 79211 Denzlingen | Apparatus for parallel micro-array experiments, e.g. in DNA analysis, has a micro-titration plate with reaction vessels and a micro-array to one side of them |
EP2419219B1 (en) * | 2009-04-15 | 2017-06-14 | Koninklijke Philips N.V. | Cartridge for an amplification process |
DE102009019476A1 (en) * | 2009-05-04 | 2010-11-11 | Biametrics Marken Und Rechte Gmbh | Recognizable carrier for optical measuring methods |
US20140320642A1 (en) * | 2011-10-28 | 2014-10-30 | Torsten Matthias | Device And Method For Detecting Substances Present In Biological Or Chemical Samples |
WO2013060482A1 (en) * | 2011-10-28 | 2013-05-02 | Torsten Matthias | Device and method for detecting substances present in biological or chemical samples |
EP4148118A1 (en) * | 2012-08-24 | 2023-03-15 | Yale University | System, device and method for high-throughput multi-plexed detection |
WO2014100626A1 (en) | 2012-12-21 | 2014-06-26 | Hutman Diagnostics AG | Microarrays |
BE1022360B1 (en) * | 2013-11-19 | 2016-03-24 | Tekinvest Sprl | MICROPLATE WELL, HOLDER AND METHOD FOR DETECTION OF ANALYTES |
CN103760335B (en) * | 2013-12-20 | 2015-10-21 | 江苏金太生命科技有限公司 | A kind of ELISA Plate |
JP6767978B2 (en) | 2014-12-03 | 2020-10-14 | アイソプレキシス コーポレイション | Analysis and screening of cell secretion profiles |
US11353448B2 (en) | 2015-02-13 | 2022-06-07 | California Institute Of Technology | Methods and compositions for quantifying metabolites and proteins from single cells |
US10712356B2 (en) * | 2015-04-21 | 2020-07-14 | General Automation Lab Technologies Inc. | Apparatus and method for picking biological sample |
US20180364243A1 (en) | 2015-12-09 | 2018-12-20 | Intuitive Biosciences, Inc. | Automated silver enhancement system |
US11300386B2 (en) | 2015-12-31 | 2022-04-12 | Dupont Safety & Construction, Inc. | Ballistic materials incorporating spunlaced nonwovens |
JP7033128B2 (en) * | 2016-10-07 | 2022-03-09 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | Methods and analytical systems for inspecting samples |
JP2019533808A (en) | 2016-10-07 | 2019-11-21 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハーBoehringer Ingelheim Vetmedica GmbH | Analysis system and method for inspecting a sample |
WO2018065113A1 (en) | 2016-10-07 | 2018-04-12 | Boehringer Ingelheim Vetmedica Gmbh | Analysis system and method for testing a sample |
DK3538891T3 (en) | 2016-11-11 | 2022-03-28 | Isoplexis Corp | COMPOSITIONS AND PROCEDURES FOR CONTEMPORARY GENOMIC, TRANSCRIPTOMIC AND PROTEOMIC ANALYSIS OF SINGLE CELLS |
WO2018098372A1 (en) | 2016-11-22 | 2018-05-31 | IsoPlexis Corporation | Systems, devices and methods for cell capture and methods of manufacture thereof |
WO2020070015A1 (en) | 2018-10-01 | 2020-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Fluid sensor, system for testing a sample and process |
AU2020401185A1 (en) * | 2019-12-10 | 2022-07-21 | Lantha Inc. | Probes for chemical analysis and related methods |
EP4077712A4 (en) | 2019-12-17 | 2024-01-24 | Lantha Inc | Mobile devices for chemical analysis and related methods |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0353589A2 (en) * | 1988-08-02 | 1990-02-07 | Abbott Laboratories | Apparatus and method for providing assay calibration data |
US5874219A (en) * | 1995-06-07 | 1999-02-23 | Affymetrix, Inc. | Methods for concurrently processing multiple biological chip assays |
US6287774B1 (en) * | 1999-05-21 | 2001-09-11 | Caliper Technologies Corp. | Assay methods and system |
WO2003059516A1 (en) * | 2002-01-16 | 2003-07-24 | Clondiag Chip Technologies Gmbh | Reaction vessel for carrying out array processes |
US20040038388A1 (en) | 2001-12-19 | 2004-02-26 | Affymetrix, Inc. | Manufacturing process for array plate assembly |
US6720149B1 (en) | 1995-06-07 | 2004-04-13 | Affymetrix, Inc. | Methods for concurrently processing multiple biological chip assays |
EP1415710A1 (en) | 2002-10-31 | 2004-05-06 | Agilent Technologies Inc | Composite flexible array substrate |
EP1473080A2 (en) * | 2003-04-30 | 2004-11-03 | Agilent Technologies, Inc. | Chemical array reading |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5412087A (en) | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
US5578832A (en) * | 1994-09-02 | 1996-11-26 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
DE69527585T2 (en) | 1994-06-08 | 2003-04-03 | Affymetrix Inc | Method and device for packaging chips |
US6287850B1 (en) * | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
US5795748A (en) * | 1996-09-26 | 1998-08-18 | Becton Dickinson And Company | DNA microwell device and method |
DE19706570C1 (en) | 1997-02-19 | 1998-02-26 | Inst Physikalische Hochtech Ev | Production of structured, self-organising molecular mono:layer |
US6238869B1 (en) | 1997-12-19 | 2001-05-29 | High Throughput Genomics, Inc. | High throughput assay system |
US6456942B1 (en) * | 1998-01-25 | 2002-09-24 | Combimatrix Corporation | Network infrastructure for custom microarray synthesis and analysis |
EP1115424A1 (en) | 1998-08-28 | 2001-07-18 | Febit Ferrarius Biotechnology GmbH | Method and measuring device for determining a plurality of analytes in a sample |
US6515039B1 (en) | 1998-08-28 | 2003-02-04 | Poly-An Gmbh | Method for the parallel and combinatory synthesis of compounds bound to a continuous polymeric solid phase supporting material |
DE60000583T3 (en) | 1999-05-19 | 2009-04-30 | Eppendorf Array Technologies | METHOD FOR IDENTIFYING AND / OR QUANTIFYING A TARGET LINK |
JP3469504B2 (en) | 1999-06-01 | 2003-11-25 | 日立ソフトウエアエンジニアリング株式会社 | Microarray chip and indexing method thereof |
IL147227A0 (en) | 1999-07-02 | 2002-08-14 | Clondiag Chip Tech Gmbh | Microchip matrix device for duplicating and characterizing nucleic acids |
US6596483B1 (en) * | 1999-11-12 | 2003-07-22 | Motorola, Inc. | System and method for detecting molecules using an active pixel sensor |
EP2230314A1 (en) * | 2000-01-31 | 2010-09-22 | The Board of Regents,The University of Texas System | Method of sensing an analyte |
AU7637601A (en) | 2000-07-01 | 2002-01-14 | Clondiag Chip Tech Gmbh | Method for qualitative and/or quantitative detecting of molecular interactions on probe arrays |
CN1137999C (en) * | 2000-07-04 | 2004-02-11 | 清华大学 | Integrated microarray device |
AU2001288360A1 (en) * | 2000-08-23 | 2002-03-04 | Genome Therapeutics Corporation | Genomics-assisted rapid identification of targets |
US6905816B2 (en) * | 2000-11-27 | 2005-06-14 | Intelligent Medical Devices, Inc. | Clinically intelligent diagnostic devices and methods |
JP2004532404A (en) * | 2001-03-28 | 2004-10-21 | ジェネテック・バイオテクノロジー・(シャンハイ)・カンパニー・リミテッド | Apparatus and method for detecting multiple analytes |
JP2002357604A (en) * | 2001-04-17 | 2002-12-13 | Nisshinbo Ind Inc | Reaction vessel and analysis method for biologically active substance using the same |
US6929944B2 (en) | 2001-08-31 | 2005-08-16 | Beckman Coulter, Inc. | Analysis using a distributed sample |
DE10142643A1 (en) | 2001-08-31 | 2003-04-24 | Clondiag Chip Tech Gmbh | Detection of interactions on probe arrays |
DE10149684B4 (en) | 2001-10-09 | 2005-02-17 | Clondiag Chip Technologies Gmbh | Device for holding a substance library carrier |
AU2002357368A1 (en) | 2001-12-19 | 2003-07-09 | Affymetrix, Inc. | Array plates and method for constructing array plates |
US20030134320A1 (en) * | 2002-01-15 | 2003-07-17 | Myriad Genetics, Incorporated | Method system and computer program product for quality assurance in detecting biochemical markers |
US20040023247A1 (en) * | 2002-07-31 | 2004-02-05 | Affymetrix, Inc. | Quality control methods for microarray production |
US7089123B2 (en) | 2002-09-30 | 2006-08-08 | Agilent Technologies, Inc | Array scanner control system |
US20040080536A1 (en) * | 2002-10-23 | 2004-04-29 | Zohar Yakhini | Method and user interface for interactive visualization and analysis of microarray data and other data, including genetic, biochemical, and chemical data |
DE10253966B4 (en) | 2002-11-19 | 2005-03-24 | Clondiag Chip Technologies Gmbh | Microarray-based method for the amplification and detection of nucleic acids in a continuous process |
US20040191810A1 (en) * | 2002-12-17 | 2004-09-30 | Affymetrix, Inc. | Immersed microarrays in conical wells |
US8007744B2 (en) | 2003-01-17 | 2011-08-30 | Greiner Bio-One Gmbh | Sample container for analyses |
DE10315074A1 (en) * | 2003-04-02 | 2004-10-14 | Clondiag Chip Technologies Gmbh | Device for the duplication and detection of nucleic acids |
US7642064B2 (en) * | 2003-06-24 | 2010-01-05 | Ventana Medical Systems, Inc. | Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest |
DE102004056735A1 (en) | 2004-11-09 | 2006-07-20 | Clondiag Chip Technologies Gmbh | Device for performing and analyzing microarray experiments |
-
2004
- 2004-11-24 DE DE102004056735A patent/DE102004056735A1/en not_active Ceased
-
2005
- 2005-11-09 EP EP05813339A patent/EP1807209A2/en not_active Withdrawn
- 2005-11-09 EP EP10179918.7A patent/EP2305383B1/en not_active Revoked
- 2005-11-09 WO PCT/EP2005/055871 patent/WO2006051088A2/en active Application Filing
- 2005-11-09 US US11/667,118 patent/US20080207461A1/en not_active Abandoned
-
2011
- 2011-10-04 HK HK11110501.8A patent/HK1156274A1/en not_active IP Right Cessation
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0353589A2 (en) * | 1988-08-02 | 1990-02-07 | Abbott Laboratories | Apparatus and method for providing assay calibration data |
US5874219A (en) * | 1995-06-07 | 1999-02-23 | Affymetrix, Inc. | Methods for concurrently processing multiple biological chip assays |
US6720149B1 (en) | 1995-06-07 | 2004-04-13 | Affymetrix, Inc. | Methods for concurrently processing multiple biological chip assays |
US6287774B1 (en) * | 1999-05-21 | 2001-09-11 | Caliper Technologies Corp. | Assay methods and system |
US20040038388A1 (en) | 2001-12-19 | 2004-02-26 | Affymetrix, Inc. | Manufacturing process for array plate assembly |
WO2003059516A1 (en) * | 2002-01-16 | 2003-07-24 | Clondiag Chip Technologies Gmbh | Reaction vessel for carrying out array processes |
EP1415710A1 (en) | 2002-10-31 | 2004-05-06 | Agilent Technologies Inc | Composite flexible array substrate |
EP1473080A2 (en) * | 2003-04-30 | 2004-11-03 | Agilent Technologies, Inc. | Chemical array reading |
Non-Patent Citations (8)
Title |
---|
"Eurolab Report", 2019, Retrieved from the Internet <URL:www.eurolab.com> * |
"Iconoclust - The imaging tool for array analysis in research and HTS.", CLONDIAG CHIP TECHNOLOGIES GMBH, 2001, pages 1 - 3, XP003026669 |
"IconoClust", 2001, Retrieved from the Internet <URL:www.clondiag.com> * |
"Microarray Data Analysis II", 2002, KLUWER ACADEMIC PUBLISHING, article J. DOPAZO: "Microarray processing and analysis", pages: 43 - 63, XP003026668, DOI: doi:10.1007/B112982 * |
DOPAZO J.: "Methods of Microarray data analysis", 2002, SPRINGER US, ISBN: 9781402071119, article "Microarray data processing and analysis.", pages: 43 - 63, XP003026668 |
E. BUFFLIER: "Dedicated OLISA TM Biochips for Multiple GMO Detection and Identification", April 2004 (2004-04-01), Retrieved from the Internet <URL:www.apibio.com> * |
MARTEL R.R. ET AL: "Multiplexed screening assay for mRNA combining nuclease protection with luminescent array detection.", ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES,, vol. 1, no. 1, 1 November 2002 (2002-11-01), pages 61 - 71, XP002484291 |
RALPH R. MARTEL ET AL: "Multiplexed Screening Assay for mRNA Combining Nuclease Protection with Luminescent Array Detection", ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, vol. 1, no. 1, 1 November 2002 (2002-11-01), US, pages 61 - 71, XP055545540, ISSN: 1540-658X, DOI: 10.1089/154065802761001310 * |
Also Published As
Publication number | Publication date |
---|---|
US20080207461A1 (en) | 2008-08-28 |
DE102004056735A1 (en) | 2006-07-20 |
EP2305383A1 (en) | 2011-04-06 |
WO2006051088A3 (en) | 2006-08-03 |
EP2305383B1 (en) | 2016-04-27 |
HK1156274A1 (en) | 2012-06-08 |
WO2006051088A2 (en) | 2006-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2305383B1 (en) | Devices for carrying out and diagnosing microarray experiments | |
EP1642644B1 (en) | Apparatus for detecting target molecules | |
EP2266699B1 (en) | Device for the amplification and detection of nucleic acids | |
EP1742058B1 (en) | Substrate for analyte determination and methods for manufacturing such substrates | |
EP2280267B1 (en) | Device and method for detecting molecular interactions | |
US20060281183A1 (en) | Analysis engine and database for manipulating parameters for fluidic systems on a chip | |
US20050135974A1 (en) | Device for preparing multiple assay samples using multiple array surfaces | |
US8877141B2 (en) | System for preparing arrays of biomolecules | |
DE19731479A1 (en) | Device for analysis of target chemicals has light emitting array | |
DE202010004968U1 (en) | sample tray | |
DE102005052752A1 (en) | Apparatus and method for detecting molecular interactions | |
EP1718411B1 (en) | A device for analysing an interaction between target and probe molecules | |
US20030044320A1 (en) | High throughput screening micro array platform | |
US20070141576A1 (en) | Biological chip and use thereof | |
DE102006027517A1 (en) | Method of generating perfect macro- and microarrays by combining preselected coated solid-phase fragments | |
EP1533036B1 (en) | Combined apparatus comprising a sample holder and a reading device | |
EP1415261A2 (en) | Method for the biochemical detection of analytes | |
US20200009561A1 (en) | Tools and methods for isolation and analysis of individual components from a biological sample | |
Adar et al. | A raman microprobe optimized for microarrays and multiple-well plates, Am |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070525 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CLONDIAG GMBH |
|
17Q | First examination report despatched |
Effective date: 20080320 |
|
TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20190701 |